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ABSTRACT 
 
To examine the transmission and relative magnitude of substituent effects in biphenyl 
compounds, we have used 4-aryl pyridine moieties as probes. Accordingly, 58 4-aryl pyridine 
type compounds have been synthesized, characterised and the acid dissociation constants 
of their conjugate acids have been determined at 298 kelvin. 
The parameter dΔG has been introduced and used to quantify substituent effects. It has 
been shown that a dichotomy exists between the transmission of electron-withdrawing 
substituents and electron donating substituents. Electron withdrawing groups in the 3 and 4 
position exhibit effects of a similar magnitude while those in the 2 position exert a stronger 
effect. In contrast, electron donating groups have been shown to exert a significant effect 
only in the 2 and 4 position. Additionally, it has been found that the cyano substituent in the 
2 position exerts an unexpectedly powerful effect while the nitro group in the same position 
exerts an unexpectedly weak effect. Crystal structures suggest the latter observation is due 
to the nitro group in the 2 position being twisted out of plane. These results indicate that 
secondary electronic effects and rotational freedom of functional groups might affect 
biphenyl geometry. Substituent effects in 4-aryl-3-picoline and 4-aryl-3,5-lutidine 
compounds have been found to be significantly weaker than in the analogous 4-aryl pyridine 
compounds, which suggests that resonance interactions between the two aryl rings are at 
least partially responsible for transmission of substituent effects. 
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LIST OF ABBREVIATIONS 
1. oC – degrees Centigrade 
 
2. h – hour(s) 
 
3. min – minutes 
 
4. RT – room temperature 
 
5. mol – moles 
 
6. eq. – equivalent(s) 
 
7. UV-vis – ultraviolet-visible 
 
8. δ - chemical shift 
 
9. ν – wavenumber 
 
10. Å - angstrom 
 
11. NMR – Nuclear Magnetic Resonance Spectroscopy 
 
12. FT-IR – Fourier Transform Infrared 
 
13. XRD – X-ray Diffraction 
 
14. HRMS – High Resolution Mass Spectrometry 
 
15. J – coupling constant (in context of NMR spectra) or joules (unit of energy) 
 
16. kJ/mol – kilojoule per mole 
 
17. THF – tetrahydrofuran 
 
18. TLC – thin layer chromatography 
 
19. TBAF – tetrabutylammonium fluoride 
 
20. SPhos - 2-Dicyclohexylphosphino-2′,6′-dimethoxybiphenyl 
 
21. PPh3 – triphenylphosphine 
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22. Pd(PPh3)4 – tetrakis(triphenylphosphine)palladium(0) 
 
23. Cs2CO3 – caesium carbonate 
 
24. K2CO3 – potassium carbonate 
 
25. TiCl4 – titanium tetrachloride 
 
26. LiAlH4 or LAH – lithium aluminium hydride 
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INTRODUCTION 
 
a) Biphenyls and Atropisomerism: 
Pattern recognition is essential to scientific inquiry, allowing not just the deduction of causal 
relationships but also the adaptation of natural trends for a select purpose. In the field of 
medicinal chemistry, pattern recognition has enabled the identification of privileged 
structures- widely applicable molecular scaffolds from which an array of useful compounds 
may be synthesized. Aryl rings constitute one such privileged class, providing for a range of 
favourable interactions with biologically relevant functional groups.1 Interactions between 
proteins and drug molecules containing aryl groups have been shown to be dominated by 
hydrophobic interactions and π-stacking.2 Aryl rings also exhibit favourable electrostatic 
interactions with amide groups3, and favourable π-cation binding.4 Not all aromatic 
structures, however, are equally valuable. A statistical analysis of NMR binding data 
conducted by Fesik et al. indicates that molecules containing a biphenyl substructure bind 
with greater selectivity and higher affinity to certain proteins than those with simple phenyl, 
napthyl or diphenylmethyl units, possibly owing to its shape and conformational flexibility.5 
As a result the biphenyl substructure is present in 4.3% of all marketed drugs, equating to 
5,658 compounds which are active towards 311 different pharmacological targets.6 Biphenyl 
moieties are also prevalent outside the realm of medicinal chemistry. Substituted biphenyls 
such as Buchwald’s XPhos7 and the derivatives of BIPHEP8 have proven to be effective 
ligands in metal catalysed processes. Furthermore, biphenyl compounds have been the 
subject of much study for their semi-conductor properties9 and are commonly encountered 
in liquid crystal technology.10 
Given the ubiquity and utility of the biphenyl motif, a more detailed examination of its 
structure is necessary. The biphenyl core is composed of two phenyl rings linked by a sigma 
bond. Energetically favourable π overlap between the two aromatic rings is maximised 
when the phenyl rings are co-planar. However, such co-planarity leads to energetically 
unfavourable steric interactions between the flanking ortho substituents.11 In an orthogonal 
conformation, the inverse is true, with the minimisation of steric repulsion being 
compensated by the loss of π overlap. The torsional angle between the planes containing 
the phenyl rings is therefore due to a compromise between steric and electronic factors, 
resulting in the phenyl rings being skewed at an angle with respect to each other in the 
ground state of the molecule.12 It is important to note, however, that the torsional angle is 
dependent upon the environment and electronic state of the molecule.11 In the crystal 
lattice of biphenyl the torsional angle tends to 0o13, as opposed to 44o in the gas phase14 and 
32o15 in solution. The torsional angle in biphenyl has also been shown to be affected by 
electronic excitation11,16 and pressure.17 
A non-zero torsional angle implies that substituted biphenyls are dissymmetric or 
asymmetric when the two sides of the molecule bridged by the sigma bond linker are not 
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identical.18 Such molecules are chiral due to a rotational axis rather than a stereogenic 
atom. Unlike compounds with point chirality, where epimerisation requires the breaking of 
bonds, the stereochemistry of an axially chiral molecule can be inverted merely by rotation 
about the axis.19 Compounds with a relatively low energy barrier to rotation about the 
stereogenic axis therefore exist as chiral rotamers that, at room temperature, rapidly 
undergo an inversion in stereochemistry.20 However, if rotation about the chiral axis is 
sufficiently hindered, the isolation of optically pure stereoisomers is theoretically possible at 
ambient conditions. These configurationally stable (relatively), axially chiral stereoisomers 
are called atropisomers. The distinction between atropisomers and rotamers is arbitrary. In 
accordance with Oki’s proposal, the rotational barrier about a chiral axis must be at least 23 
kcal/mol – equivalent to a half-life of 1000 seconds at 298K- for the stereoisomer containing 
it to be considered an atropisomer.18 
As with point-chiral molecules, convention exists for assignment of absolute 
stereodescriptors to atropisomers, illustrated below (Figure 1) using the example of 6,6’-
dinitro-2,2’-biphenyldicarboxylic acid (the first enantiomerically pure atropisomer to be 
isolated21). A reference point is first chosen so as to obtain a Newman projection of the 
molecule about the chiral axis. The substituents immediately adjacent to the axis are then 
assigned priority in accordance with the Cahn-Ingold-Prelog rules22, starting with the 
substituents of the proximate ring and assigning lower priority to substituents of the distal 
ring.23 The sequential path from the substituent of second-highest priority to the 
substituent of third-highest priority then gives the stereodescriptor; a clockwise path 
corresponds to a Ra configuration while an anti-clockwise path corresponds to a Sa 
configuration.23 The labels M (minus rotation) and P (plus rotation) may usually (with certain 
exceptions) be used in lieu of Ra and Sa respectively.27 
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Figure 1 : assignment of stereodescriptors to axially chiral compounds 
 
Atropisomerism is prevalent in both naturally occurring and synthetic compounds. Examples 
include the anti-plasmodial agent knipholone24 (Figure 2) and gossypol (Figure 2), whose M 
enantiomer has been shown to possess potent anti-fertility and anti-cancer properties.25 Both 
aforementioned compounds contain a chiral biaryl axis. However, since the criterion for 
atropisomerism is merely slow rotation about a stereogenic axis, compounds containing 
various types of chiral axes have been found. These include vancomycin (Figure 3), which 
possesses two chiral aryl-ether linkages within rotationally hindered macrocycles in addition 
to a chiral biaryl axis12, telenzepine (Figure 3), which is chiral due to a hindered amide bond26, 
and abyssomycin C (Figure 3), which has a rotationally hindered carbonyl-vinyl bond within 
an 11 membered ring.27 Keller et al. have reviewed some biologically active atropisomeric 
compounds, representing a range of rotationally hindered chiral axes.27 
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Figure 2 : naturally occurring atropisomeric compounds with chiral biaryl axes 
 
Figure 3: examples of some types of chiral axes that can lead to atropisomerism 
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b) Rotational Barriers/Atropisomerisation rates: 
i)  In Biologically active compounds: 
Enantiomers are topologically equivalent and behave identically in achiral environments.28 
Biological systems, however, are inherently chiral. Consequently, the enantiomers of 
biologically active compounds frequently exhibit different pharmacodynamic and 
pharmacokinetic properties29, as in the case of thalidomide.30 Similar to point-chiral 
enantiomers, atrop-enantiomeric compounds can also differ in their biological activities. Zask 
et al. have reviewed some compounds whose atropisomers exhibit divergent 
pharmacological behaviour.31 
The ability of atropisomers to undergo stereoinversion spontaneously via bond rotation adds 
a level of complexity to drug design. LaPlante et al. have categorized atropisomeric 
compounds according to their racemisation half-lives.8 According to this categorisation, 
compounds with half-lives less than an hour are categorized as Class 1 atropisomers, those 
with half-lives ranging several hours to days have been classified as Class 2 atropisomers, and 
finally compounds with half-lives in the order of years have been classified as Class 3 
atropisomers.19 While Class 1 atropisomers can be developed as racemic mixtures and Class 
3 atropisomers can be developed as either a single stereo-isomer or as racemic mixtures, 
Class 2 atropisomers pose a considerable challenge in drug design.19 Thus, means of 
identifying Class 2 atropisomers and altering their structure to produce similarly efficacious 
compounds with significantly lower or higher half-lives of racemisation are crucial to the 
pharmaceutical industry.  
Given the fact that biphenyls are a privileged scaffold in biologically active compounds, a 
qualitative understanding of factors influencing the barrier to rotation in biphenyl species 
would be useful and a predictive model even more so.  
 
ii) In Synthetic Chemistry: 
While stereolabile atropisomers pose a challenge in drug design, they are of considerable 
utility to the synthetic chemist. Configurationally unstable atrop-enantiomers exist as rapidly 
equilibrating racemic mixtures, making them ideal candidates for participation in dynamic 
kinetic resolutions. On the other hand, atrop-diastereomers can be thermally equilibrated to 
achieve, under the right conditions, a desired diastereomeric configuration. This latter 
strategy has been employed to great effect in Boger’s total synthesis of the vancomycin 
aglycon. The vancomycin aglycon (Figure 4, stereogenic axes shown in bold) consists of three 
macrocycles. A key feature of Boger’s synthesis is an analysis of the barrier to rotation about 
each chiral axis and subsequently, assembly of the macrocycles in descending order of the 
barrier to rotation about the chiral axis they contain.32,33 The synthesis of each macrocycle is 
followed by diastereomeric enrichment via thermal equilibration.33  
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Figure 4: Vancomycin aglycon 
 
Due to the order in which the macrocycles are synthesized, the configuration of each chiral 
axis is unperturbed by thermal equilibration of its successor macrocycle.12,32 Furthermore, 
this approach allows recycling of undesired diastereomers, thereby improving overall 
efficiency of the synthesis.12 
Clayden has synthesized enantiopure N,N-dialkyl benzamides by exploiting stereolabile aryl-
amide bonds. Clayden’s method involves introduction of a chiral centre ortho to the aryl-
amide bond so as to enforce a large diastereomeric bias.34 Consequently, this modified 
benzamide adopts the favoured diastereomeric configuration (made possible by ease of 
rotation about the stereogenic axis). Next, the aryl ring is further functionalized in order to 
raise the barrier to rotation about the aryl-amide bond.34 Finally, the initially added chiral 
centre is removed to furnish an enantiopure, functionalized, configurationally stable 
benzamide.34 
Bringmann’s knipholone total synthesis relies on rapid and reversible epimerisation of an 
atrop-enantiomeric lactone. This so called “lactone approach” involves a Corey-Bakshi-
Shibata (CBS) reduction on the stereolabile lactone precursor35 (Figure 5). The 
stereochemistry of the biaryl axis in the product is therefore set up in a chiral reagent 
mediated dynamic kinetic resolution.  
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Figure 5: Stereodetermining step in Bringmann’s knipholone synthesis 
 
An organocatalytic, atropo-enantioselective tribromination of 3’-hydroxybiphenyl-3-
carboxylic acid has been reported by Miller in which the stereodetermining step is a dynamic 
kinetic resolution of the substrate and possibly, the mono and di brominated intermediates.36 
Asymmetric catalysis works by using a chiral catalyst to convert enantiomeric transition states 
into non-isoenergetic diastereomeric transition states. The pre-requisite for such a process to 
work is, of course, that the configuration of the catalyst remain constant over the catalytic 
cycles. The atropisomeric ligands BINAP and BINOL are a privileged set of asymmetric 
catalysts, having been effectively applied in a wide range of reactions.37 Both BINOL and 
BINAP are configurationally stable, with extremely high barriers to rotation about the biaryl 
axis of 155 kJ/mol and 213 kJ/mol respectively.38,39 This high stereochemical stability implies 
that when used as a source of chirality in asymmetric inductions, these compounds are useful 
only in an enantiomerically pure form, necessitating either a preparative resolution or atropo-
enantioselective transformation to make them- which increases the cost of synthesising these 
ligands. Furthermore, when used in conjunction with chiral activators (i.e a second chiral 
ligand), such ligands form a diastereomeric mixture of catalytic species where one of the 
diastereomers possesses sub-optimal geometry.40 Mikami et al. have used stereolabile, 
axially chiral ligands such as 2,2’-bis(diphenylphosphino)-1,1’-biphenyl (BIPHEP, shown in 
Figure 6) to overcome these problems.  
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                                                                      Figure 6: BIPHEP 
Figure 7 depicts the use of a combination of BIPHEP and a chiral bidentate ligand to synthesize 
a diastereomerically pure metal complex.  
 
 
Figure 7: Preparation of a diastereopure complex of BIPHEP using a chiral activator 
The chiral activator - in this example the chiral bidentate ligand - with configuration “*”, on 
co-ordinating to the metal-BIPHEP complex, forms a mixture of diastereomeric complexes Ra* 
and Sa*, which through rotation about the biphenyl axis in BIPHEP undergo temperature 
controlled resolution to yield a diastereomerically enriched mixture of Ra* as the catalytic 
species.40 A wide range of reactions catalysed by BIPHEP complexes of ruthenium, palladium, 
platinum and gold have been reported by Mikami, with BIPHEP complexes in certain cases 
delivering better enantioselectivities than analogous BINAP complexes.41 Leitner et al. have 
recently used BIPHEP-rhodium complexes in conjunction with a proline derived chiral 
activator to achieve enantioselective hydrogenation of 2-acetamidoacrylates and 
hydroboration of styrene.42 
A necessary condition for all the transformations described above is that the stereogenic axis 
in the substrate (or ligand) must undergo rapid inversion in stereochemistry and the same 
axis in the product must be stable enough to maintain its configuration under reaction 
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conditions. The ability to estimate the barrier to rotation in atropisomeric compounds would 
be therefore be valuable while planning synthetic routes- particularly in the case of biphenyls 
which appear in several utilitarian molecules. 
 
c) Torsional angles: 
The Eyring equation (Equation 1) specifies the barrier to rotation about a molecular axis as 
the difference between the free energy of the ground state molecule and free energy of the 
transition state the molecule must go through to complete one rotation. 
 
 The ground state energy of biphenyls is, as discussed above, an outcome of two opposing 
forces- steric repulsion and π overlap- which results in a torsional angle between the phenyl 
rings. All other geometric parameters of the biphenyl system remaining constant, this 
torsional angle gives a correlation between the geometry of the molecule and its free 
energy.16 Besides being critical to calculating ground state energies, the torsional angle 
significantly affects electronic properties of biphenyls as well as the projection of substituents 
into space. The torsional angle is therefore in an important parameter in drug design, 
molecular electronics and synthetic chemistry. 
Biologically active molecules interact with proteins that possess a specific shape and 
conformation.27 Drug-receptor interactions therefore vary with the geometry of the drug 
molecule and the shape of such molecules needs to be optimized.43 In the case of molecules 
containing the biphenyl moiety, this implies that the torsional angle can play an important 
role in the biological effects of the molecule. For instance, Lai et al. have found that the 
efficacy of ABCC2/MRP2 protein (responsible for drug resistance) inhibition by biphenyl 
substituted pyrazoles depends upon the torsional angle in the biphenyl substituent44 and a 
study by Khim and Chang suggests the toxicity of polychlorinated biphenyls is affected by 
torsional angle dependant dipole moments.45  
Biphenyls have also been extensively studied for molecular electronic applications due to the 
variation of several properties of biphenyl based junctions with torsional angles.46 Examples 
include torsional angle dependant sensitivity of electric conductance to terahertz radiation in 
bipyridyl systems 46, conductance of 4,4’-disubstituted biphenyls47, Seebeck effect of biphenyl 
junctions48,  and the rectifier characteristics of substituted biphenyl based devices49. 
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With regard to synthetic methodology, it has been shown that biaryl torsional angles can 
influence reaction outcomes. Page and co-workers have developed a methodology for 
enantioselective epoxidations catalysed by N-substituted biaryl azepinium salts (Figure 8).50 
The enantioselectivities of epoxidations catalysed by these biaryl azepinium salts have been 
found to correlate to the torsional angle in the biaryl moiety present in the catalyst50 
(although no rationale for this correlation has presently been provided by the authors).  
 
Figure 8: Page’s Biaryl azepinium salt catalysed stereoselective epoxidation 
Abboud et al. have reported an enantioselective hydroformylation of allyl nitrile and vinyl 
acetate catalysed by rhodium complexes of a biphenyl bridged bisphosphate ligand.51 In this 
case, enantioselectivity and regioselectivity of the hydroformylation depend upon the 
torsional angle of the biphenyl bridge (circled in Figure 9) contained within the ligand which, 
as suggested by DFT calculations, is due to dependence of ligand bite angle on the torsional 
angle of the biphenyl bridge.51 
 
Figure 9: Biphenyl bridged catalyst for asymmetric hydroformylation (Abboud et al.) 
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d) Measuring rotational barriers, atropisomerisation rates, and torsional angles: 
A survey of the chemical literature clearly indicates the value of being able to predict barriers 
to rotation and torsional angles in biphenyl compounds. In response to this need, several 
methods of determining rotational barriers have been reported. In principle, any analytical 
technique that can discriminate between atropisomers can be used to determine barriers to 
rotation, although the magnitude of this barrier dictates which technique is most suitable. For 
all the methods described below, it is assumed that the racemisation of biphenyl 
atropisomers is a first order reversible process. 
Dynamic Nuclear Magnetic Resonance (D-NMR) methods have been applied to determine the 
barrier to rotation in atropisomeric biphenyls that racemise on the NMR timescale. A pre-
requisite for such methods is that the molecule under study must contain a diastereotopic 
group such that the diastereotopic peaks appear at significantly different frequencies at 
accessible temperatures.52 Several groups have used line shape analysis and the coalescence 
method to calculate the free energy of rotation about the stereogenic axis in atropisomeric 
biphenyls.53-56 Notably, Sternhell et al. have examined the steric bulk of various functional 
groups using 1,1-dimethyl-5-substituted-6-(o-substituted phenyl) indanes (Figure 10a) as 
probes. The geminal dimethyl group incorporated into these probes provides the 
diastereotopic protons necessary for tracking atropisomerisation and rate constants are thus 
determinable through line shape analysis.52 In a modification of Sternhell’s approach, 
Mazanti, Ruzziconi and Schlosser have determined free energy of activation values for 
racemisation of various 3-isopropyldimethylsilyl-2’-substituted biphenyls (Figure 10b) using 
NMR line shape analysis and have proposed the use of these free energy values (designated 
“B values” by the authors) as a measure of a functional group’s steric bulk.57 While the B 
values reported by Ruzziconi et al. largely follow the same trends in steric bulk as those 
indicated by A values, the accuracy of B values as a measure of steric bulk depends upon the 
assumption that the electronic effect of a substituent on atropisomerisation barriers is 
insignificant compared to the steric effect of that substituent. Consequently, a few 
discrepancies arise in the case of substituents generally considered to have strong electronic 
effects. For instance, a comparison between the A values of the amino (NH2) group and the 
dimethylamino (N(CH3)2) group suggests that the former, with an A value of 1.2 kcal/mol, is 
less “bulky” than the latter which has an A value of 2.1 kcal.mol. 57 In contradiction, the B 
values of the NH2 group and N(CH3)2 group- 8.1 kcal/mol and 6.9 kcal/mol respectively- 
indicate the opposite. 57 Contradictions like these raise the possibility that electronic effects 
indeed play a significant role in determining atropisomerisation rates, as will be discussed in 
the proceeding section. 
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Figure 10: Biaryl probes containing diastereotopic groups 
 
For atropisomeric biphenyls with large racemisation barriers, dynamic chromatographic 
techniques can be employed for determination of rate constants and thermodynamic data. 
Dynamic High Performance Liquid Chromatography (D-HPLC) methods have been shown to 
be suitable for biphenyls with racemisation barriers of 65-105 kJ/mol while Dynamic Gas 
Chromatogaphy (D-GC) methods have been used for compounds with higher racemisation 
barriers falling in the 70-140 kJ/mol range.58 The basic procedure for these techniques 
involves separation of a racemic mixture of atropisomers such that the combined effect of 
elution and racemisation yields elution profiles which, upon matching with computer 
simulated elution profiles, give rate constants for the racemisation process.59,60 Activation 
parameters can then be obtained by determining rate constants at multiple temperatures. 
Koenig and co-workers have studied racemisation barriers in a number of substituted 
biphenyl compounds by D-GC and D-HPLC. From these experiments, Koenig et al. have 
reported an increase in racemisation barriers due to electron withdrawing groups and 
decrease in racemisation barriers due to electron donating groups in the case 4,4’-
disusbstituted-2,2’-bis(trifluoromethyl)biphenyls (Figure 11a).61 They have also observed a 
“buttressing effect” in 3-alkyl-2,2’-disubstituted biphenyls where the presence of the alkyl 
group prevents bending of the 2-substituent away from the opposite aryl ring(Figure 11c).62 
Interestingly, Koenig et al. have also found that the effect of electron withdrawing and 
electron donating substituents in 4,4’-disusbstituted-2,2’-diisopropylbiphenyls (Figure 11b) 
follows a trend opposite to the one observed in 2,2’-bis(trifluoromethyl) analogues.62 The 
authors have postulated a favourable interaction between the benzylic protons and the π-
electron cloud of the neighbouring phenyl ring to explain this observation.62  
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Figure 11: Biaryl moieties investigated by Koenig et al. 
 
Other studies of biphenyl racemisation rates by chromatography include Bihlmeier, Mayor, 
and Klopper’s determination of racemisation barriers, activation parameters and substituent 
effects in atropsiomeric 4,4’-disubstituted-2,2’-butyl bridged biphenyls (Figure 12) by D-HPLC 
which, like the findings of Koenig et al, indicate that electron withdrawing substituents 
increase atropisomerisation barriers while electron donating substituents decrease them.63 
Most recently, Wessig and Trapp have reported the use of D-HPLC for determination of 
racemisation barriers in various BIPHEP derivatives.64  
 
Figure 12: Butyl bridged biphenyl moiety examined by Bihlmeier et al. 
In the case of charged biphenyls, capillary electrophoresis presents itself as a technique for 
studying atropisomerisation. Unlike the aforementioned chromatographic methods, no 
simulated elution profile is required for estimation of rate constants with capillary 
electrophoresis.58 Instead, the electrophoretic method involves resolution of a racemic 
mixture of enantiomers, followed by selective heating of one enantiomer.58 The rate constant 
for racemisation can then be calculated by tracking the racemisation profile of each 
enantiomer over time.58 Koenig et al. have applied capillary electrophoresis for calculating 
the free energy of activation for the racemisation of water soluble 2,2’-bis-(trifluoromethyl)-
4,4’-diammonium biphenyl and 2,2’-diisopropyl-4,4’-diammonium biphenyl .58 
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Vibrational Circular Dichroism (VCD) and Electronic Circular Dichroism (ECD) spectroscopy has 
proven very useful for detecting stereoisomerism and assigning configuration in 
pharmaceuticals65,66 and natural products.27 In CD spectroscopy the bands produced by a 
chiral molecule are opposite in sign to those produced by its enantiomer.67 With the help of 
computational methods, absolute configuration can be correlated to CD spectra.27 Pivonka 
and Wesolowski have used VCD spectroscopy for calculating the atropisomerisation rates in 
certain GABA modulators containing a rotationally hindered biphenyl motif. By tracking the 
intensity of CD bands of an initially enantiopure analyte over time, the racemisation rate can 
be calculated assuming first order kinetics for the process.67 
Computational methods, and in particular high level DFT modelling, have also been applied 
extensively towards calculating racemisation rates of biphenyl species- either in combination 
with spectroscopic57 or chromatographic techniques64, or as stand-alone computational 
simulations.68,69 Masson has calculated theoretical racemisation rates for 46 atropisomeric 
biphenyl compounds and has identified the hybrid functional approximations B3LYP-D, B97- 
D and TPSS-D3 as promising tools for estimating rotational barriers in biphenyl compounds.70 
DFT computations have also been widely used for calculating another important parameter 
in biphenyls: the torsional angle. Muchall et al. have, for instance, studied the effect of 
substituents on the torsional angle of biphenyl compounds and have suggested the use of 
electronic excitation potentials for predicting biphenyl geometry.71 Sierra et al. have used DFT 
calculations to examine the variation of torsion angle with changing substituents in 4-amino-
4’-substituted biphenyls and have suggested that steric factors are the dominant contribution 
to torsional angle, unless the substituents produce a strong “push-pull” effect between the 
two phenyl rings.72 
Various spectroscopic methods provide an empirical alternative to torsional angle 
determination in biphenyls. By exploiting the correlation between spectral properties and 
degree of conjugation between the phenyl rings or the geometry of the biphenyl compound, 
torsional angles can be estimated using UV73 and IR74 spectroscopy. Based on a correlation 
between first and fourth ionisation potentials in biphenyls, photo-electron spectroscopy has 
also been employed for calculating torsional angles in polychlorinated biphenyls.75 NMR 
spectroscopy, well known for its efficacy at elucidating structural features, has been applied 
towards calculating torsional angles in biphenyls- either on the basis of predictive equations76, 
or by FIREMAT experiments using 13C solid state spectra.77 Additionally, X-Ray Diffraction 
(XRD) has been used to obtain solid state structures of several biphenyl compounds. Leroux 
has published an analysis of the crystal structures of mono and di-halogenated biphenyls, 
supplemented by DFT calculations, to identify the effects of fluorine substitution on biphenyl 
torsional angles.78 
Using the methods described above, it is possible to study electronic and steric effects on 
atropisomerization barriers by calculating racemization rates in a range of substituted chiral 
biphenyls. We elected to explore 4-aryl pyridine moieties as probes, reasoning that changes 
in the electronic and steric nature of the 4-aryl substituent would affect the degree of 
conjugation between the aryl substituent and the pyridine ring, thereby influencing the 
basicity of the molecule. Under this assumption, the basicity constants of these pyridine 
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probes can be used for a qualitative study of substituent effects on the ground state geometry 
of the probe. We also hoped to use the data derived from these basicity constants to develop 
a semi-empirical, computationally aided model for predicting ground state geometry and 
barriers to rotation in biphenyls. The work presented in the following sections details the 
synthesis of a library of 4-aryl pyridines, 4-aryl-3-picolines and 4-aryl-3,5-lutidines, the 
measurement of the acid dissociation constants (Ka’s) of the conjugate acids of these 
compounds, and a qualitative discussion of substituent effects based on the Ka’s so obtained. 
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STRUCTURE-BASICITY RELATIONSHIPS OF 4-ARYL PYRIDINE MOIETIES 
 
PREMISE 
The aim of this project was to develop a computational model to predict ground state 
geometries and rotational barriers in substituted biphenyls. Previous simulations have shown 
that the effect of substituents on these two parameters tend to be dominated by steric 
repulsions between the flanking ortho substituents (indicated by R1, R2, R3, and R4 in Figure 
13).68,72 However, the electronic effect of substituents on the two rings has also been shown 
to be significant.62,72 For instance, Grein has suggested that the geometry of 2,2’-
dihalobiphenyls cannot be explained on the basis of steric effects alone.68 Additionally, 
Gomez-Gallago’s simulations have indicated that certain substituents significantly affect 
biphenyl geometry by exerting an electronic effect72 and the empirical studies of Konig and 
others show that the electronic effects of substituents produce significant variation in 
biphenyl rotational barriers.61,62  
 
Figure 13: Biphenyl compound with flanking ortho substituents 
It appears, therefore, that a model designed to estimate ground state geometries and 
rotational barriers in substituted biphenyls will need to account for the electronic effects of a 
substituent. Since there is a significant resonance interaction between the two aryl rings of a 
biphenyl molecule79, we reasoned that the electronic effect of a substituent on one of the 
rings would also induce an effect on the second ring. Measuring the effect of a substituent on 
the ring to which it is not directly attached might therefore indicate the effect of substituents 
on the degree of π overlap between the two aryl rings and by extension, the torsional angle 
of the biphenyl molecule and the energy of its ground state. 
Hammett constants have traditionally been used as a quantitative measure of the electronic 
effect of a substituent.80 Furthermore, quantum chemical parameters have been previously 
calculated by using Hammett constants as an empirical guide81, which could potentially be 
useful for our purpose. Hammett constants for a substituent are calculated from the effect of 
a substituent on the acid dissociation constant of a reference carboxylic acid.82 Since we were 
interested in the biphenyl system, this would imply measuring the acid dissociation constants 
of 4-aryl benzoic acids (Figure 14, where “X” denotes the substituent). Byron et al. have 
previously reported the acid dissociation constants of these compounds.83,84 However, the 
difference in acid dissociation constant produced by various substituents in the 4-aryl benzoic 
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acid probe is small (most substituents produced a difference in pKa
 of less than 0.2 units).83,84 
Furthermore, in the case of 4-aryl benzoic acids, the reactive centre- the carboxylic acid 
functionality- is not a part of the biphenyl system but is instead conjugated to it.  
 
Figure 14: Biphenyl carboxylic acid moiety examined by Byron et al. 
To study substituent effects on the biphenyl system, we chose to use 4-aryl pyridine moieties 
(Figure 15) as probes instead. These would have the advantage of having the reactive centre- 
the basic nitrogen in the pyridine ring- incorporated into the aromatic system, providing a 
closer match to the biphenyl species we intended to model.    
  
Figure 15: 4-aryl pyridine moiety selected for this study 
Accordingly, a series of 4-aryl pyridines was synthesized. The substituents on the aryl ring 
were chosen on the basis of their steric bulk (as quantified by A values85), on their electron 
donating or electron withdrawing capacity (as quantified on the basis of Hammett constants 
in both meta (σm) and para positions (σp)82), and on basis of the substituent possessing π-
acceptor or π-donating orbitals. Table 1 lists the substituents chosen for study along with their 
A values and Hammett constants. In addition to the 4-aryl pyridine series, we also synthesized 
a library of 4-aryl-3-picolines and 4-aryl-3,5-lutidines in order to study the effect of increasing 
steric bulk in the flanking ortho positions on the effect of the various substituents. Where 
possible, we also obtained crystal structures of the compounds synthesized, since these have 
been used previously to guide torsional angle simulations.68 
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Substituent A value 
(kJ/mol) 
σm* σp* 
Methyl  
(CH3) 
7.1 -0.07 -0.17 
Methoxy 
(OCH3) 
3.1 0.12 -0.27 
Trifluoromethyl 
(CF3) 
8.8 0.43 0.54 
Nitro 
(NO2) 
4.6 0.71 0.78 
Cyano 
(CN) 
0.9 0.56 0.66 
               *: a negative σ value indicates an electron withdrawing effect 
                        a positive σ value indicates an electron donating effect                         
Table 1: A values and Hammett constants for substituents selected for this study 
 
 
SYNTHESIS 
 
The functional group tolerance of the Suzuki-Miyaura coupling86, in conjunction with the 
commercial availability of a wide range of boron nucleophiles, led us to the conclusion that 
this versatile reaction would be an efficient way of assembling the desired 4-aryl pyridine 
species. Furthermore, Marks et al. have previously reported the superiority of the Suzuki-
Miyaura (SM) coupling over the Negishi and Stille couplings for the synthesis of sterically 
hindered 4-xylyl-3,5-lutidine-N-oxides.87 Accordingly, a procedure for arylboronic acid-
bromopyridine coupling was borrowed from the literature88 and the reaction between 
phenylboronic acid and 4-bromopyridine hydrochloride (both commercially available) was 
used to test reaction conditions. Following purification by column chromatography, 4-
phenyl pyridine, 1a, was obtained in 93% yield using the literature procedure after 16 hours 
of refluxing the two coupling partners in a 4:1 mixture of glyme and water with 2 
equivalents of caesium carbonate and 5mol% tetrakis(triphenylphosphine) palladium(0) 
(Pd(PPh3)4).  
Heating the same reaction mixture to 100oC in a microwave reactor significantly shortened 
reaction times, giving 1a in 95% yield within an hour. In comparison, refluxing the reaction 
mixture over the same duration gave a 59% yield of 1a. It was observed that significant 
amounts of a fine black powder were deposited on the walls of the reaction vial after 
microwave irradiation. Suspecting that this powder was elemental palladium and that this 
loss of palladium during the reaction was negatively affecting yields, we added a sub-
stoichiometric amount of tetrabutylammonium fluoride (TBAF) solution to the reaction 
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mixture- reasoning that the added fluoride would form in situ a fluoro-palladium anionic 
species with a lipophilic counter-ion and therefore keep the palladium in solution. 
Gratifyingly, the addition of TBAF resulted in significant improvements in yield, particularly 
for boron nucleophiles containing strong electron withdrawing groups such as 2-
nitrophenylboronic acid pinacol ester (Table 2). However, the precipitation of the black 
powder persisted even in the presence of TBAF and without further investigation an 
explanation for the increase in yield upon addition of fluoride cannot be provided.  
Compound  Yield with 0mol% TBAF Yield with 20mol% TBAF 
4-(3-methoxyphenyl)-
pyridine 
59% 78% 
4-(2-trifluoromethylphenyl)-
pyridine 
48% 75% 
4-(2-nitrophenyl)-pyridine 
 
15% 34% 
Table 2: Effect of added TBAF on SM coupling yields 
 
 
 
 
Scheme 1: Synthesis of 4-aryl pyridines  
 
Eighteen 4-aryl pyridines- compounds 1a-r- were synthesized using the reaction conditions 
described above (Scheme 1) followed by flash chromatography for purification. Yields of the 
isolated products are given below (Table 3), with the designation of the substituent on the 
aryl ring given alongside the compound name. 
 
Compound 
 
Substituent Designation Yield (in nearest 
whole number %) 
4-phenyl pyridine 
 
H 1a 95 
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Table 3: Isolated yields of 4-aryl pyridine compounds 
 
4-(2-methylphenyl)-
pyridine 
 
2CH3 1b 75 
4-(3-methylphenyl)-
pyridine 
 
3CH3 1c 95 
4-(4-methylphenyl)-
pyridine 
 
4CH3 1d 95 
4-(2,4-dimethylphenyl)-
pyridine 
2CH3+4CH3 1e 83 
4-(2-methoxyphenyl)-
pyridine 
2OCH3 1f 91 
4-(3-methoxyphenyl)-
pyridine 
3OCH3 1g 78 
4-(4-methoxyphenyl)-
pyridine 
4OCH3 1h 80 
4-(2,4-dimethoxyphenyl)-
pyridine 
2OCH3+4OCH3 1i 80 
4-(2-
trifluoromethylphenyl)-
pyridine 
2CF3 1j 74 
4-(3-
trifluoromethylphenyl)-
pyridine 
3CF3 1k 52 
4-(4-
trifluoromethylphenyl)-
pyridine 
4CF3 1l 75 
4-(2-nitrophenyl)-pyridine 
 
2NO2 1m 34 
4-(3-nitrophenyl)-pyridine 
 
3NO2 1n 66 
4-(4-nitrophenyl)-pyridine 
 
4NO2 1o 78 
4-(2-cyanophenyl)-
pyridine 
 
2CN 1p 81 
4-(3-cyanophenyl)-
pyridine 
 
3CN 1q 81 
4-(4-cyanophenyl)-
pyridine 
 
4CN 1r 69 
28 
 
 
At a later stage, we also needed to synthesize compounds 1s-x (Figure 16). 
 
 
Figure 16: Clockwise: 4-(2-hydroxymethyl)-pyridine, 4-(2-formyl)-pyridine, 4-(2-
carbomethoxy)-pyridine, 4-(4-carbomethoxy)-pyridine, 4-(4-formyl)-pyridine, 4-(4-
hydroxymethyl)-pyridine  
 
1u and 1v were synthesized via the SM coupling of 4-pyridylboronic acid with 2-
bromobenzaldehyde and 4-bromobenzaldehyde respectively under reaction conditions 
identical to those used for producing compounds 1a-r. Similarly, the SM coupling of 4-
pyridylboronic acid with methyl 2-iodobenzoate and methyl 4-bromobenzoate furnished 1w 
and 1x (Scheme 2).  
 
 
29 
 
Scheme 2: Synthesis of 1u-v and 1w-x 
 
The reduction of 1u and 1v using sodium borohydride (NaBH4) (Scheme 3) gave compounds 
1s and 1t.  
 
 
 
Scheme 3: Reduction of 1u/v to 1s/t 
 
Compounds 1s-x were thus isolated in yields shown in Table 4. 
 
 
Compound Substituent Designation Yield (in nearest 
whole number %) 
4-(2-
hydroxymethylphenyl)-
pyridine 
2CH2OH 1s 76 
4-(4-
hydroxymethylphenyl)-
pyridine 
4CH2OH 1t 74 
4-(2-formylphenyl)-
pyridine 
 
2CHO 1u 62 
4-(4-formylphenyl)-
pyridine 
 
4CHO 1v 75 
4-(2-
carbomethoxyphenyl)-
pyridine 
2CO2CH3 1w 47 
4-(4-
carbomethoxyphenyl)-
pyridine 
4CO2CH3 1x 56 
Table 4: Isolated yields of compounds 1s-x 
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Synthesis of the picoline and lutidine libraries necessitated the preparation of suitable 
electrophiles. A previously reported procedure89 (Scheme 5) was used to obtain 4-bromo-3-
picoline and 4-bromo-3,5-lutidine starting from 3-picoline-N-oxide and 3,5-lutidine 
respectively. 3,5-lutidine was oxidised to its N-oxide using hydrogen peroxide and acetic acid. 
3-picoline-N-oxide was obtained commercially. Both N-oxides were nitrated using a sodium 
nitrate-sulfuric acid mixture followed by bromination to furnish the two 4-bromo-N-oxides. 
These were then reduced by zero valent titanium, generated in situ from titanium 
tetrachloride and lithium aluminium hydride, to obtain the desired products.  
Freshly purified 4-bromo-3-picoline appeared as a colourless viscous oil. Over the course of a 
few hours, however, this oil turned reddish-brown. Yields of SM couplings using this sample 
of 4-bromo-picoline were inconsistent and decreased with each subsequent reaction. 
Furthermore, addition of the discoloured sample to an aqueous alkaline solution produced 
bright red mixtures, indicating that 4-bromo-3-picoline was spontaneously suffering some 
form of chemical change. A literature search revealed that 4-halo pyridine moieties undergo 
oligomerisation, initiated by SNAr attack of the pyridine nitrogen on the 4 position of a second 
4-halo pyridine.90 This problem was overcome by storing 4-bromo-3-picoline and 4-bromo-
3,5-lutidine as their hydrochloride salts which, on the basis of 1H Nuclear Magnetic Resonance 
(NMR) spectra, were stable for at least five months at 0oC. 
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Scheme 5: Synthesis of 4-bromo-3-picoline and 4-bromo-3,5-lutidine 
We also explored the possibility of using picoline and lutidine diazonium salts as 
electrophiles since the SM coupling of aryl diazonium salts is well documented.91 The 
reduction of 4-nitro-3-picoline-N-oxide to 4-amino-3-picoline was achieved in moderate 
yield using 3 equivalents of Ti(0). However, the attempted diazotisation of 4-amino-3-
picoline resulted in exothermic decomposition of the substrate. This is consistent with 
reports of 4-diazopyridinium salts being unstable.92 While Filimonov et al. have exploited 
the inherent instability of 4-diazopyridinum salts for the conversion of 4-aminopyridines to 
pyridyl triflates93, we decided not to apply this protocol since aryl bromides have been 
shown to be better electrophiles for the SM coupling than aryl triflates.94 
Having prepared the 4-bromo-3-picoline and 4-bromo-3,5-lutidine salts, we turned our 
attention to their SM coupling. Anticipating a slower cross-coupling reaction for these 
electrophiles due to the increased steric hindrance about the 4 position, we changed our 
catalytic system from Pd(PPh3)4 to a combination of palladium (II) acetate as pre-catalyst 
and Buchwald’s SPhos ligand.95 Palladium-SPhos complexes have previously been shown to 
be effective catalysts for the SM coupling of sterically hindered diortho substituted arenes.95  
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Scheme 6: Synthesis of 4-aryl-3-picolines 
 
Using the reaction conditions shown in Scheme 6, moderate to good yields (Table 5) of the 
4-aryl-3-picolines 7a-r were obtained.  
 
: A values and Hammett constants for substituents selected for this study 
Compound 
 
Substituent Designation Yield (in nearest 
whole number %) 
4-phenyl-3-picoline 
 
H 7a 83 
4-(2-methylphenyl)-3-
picoline 
2CH3 7b 57 
4-(3-methylphenyl)-3-
picoline 
3CH3 7c 87 
4-(4-methylphenyl)-3-
picoline 
4CH3 7d 72 
4-(2,4-dimethylphenyl)-3-
picoline 
2CH3+4CH3 7e 51 
4-(2-methoxyphenyl)-3-
picoline 
2OCH3 7f 82 
4-(3-methoxyphenyl)-3-
picoline 
3OCH3 7g 67 
4-(4-methoxyphenyl)-3-
picoline 
4OCH3 7h 56 
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Table 5: Isolated yields of 4-aryl-3-picolines 
 
 
A higher temperature of 125oC was required for the SM couplings of 4-bromo-3,5-lutidine. 
Low to moderate yields were obtained for most of the 4-aryl-3,5-lutidines (Table 6). 12p was 
isolated with a poor 12% yield while reactions with 2-nitrophenylboronic acid pinacol ester 
and 2-trifluoromethylphenylboronic acid failed to return any product.  
 
4-(2,4-dimethoxyphenyl)-
3-picoline 
2OCH3+4OCH3 7i 84 
4-(2-
trifluoromethylphenyl)-3-
picoline 
2CF3 7j 49 
4-(3-
trifluoromethylphenyl)-3-
picoline 
3CF3 7k 55 
4-(4-
trifluoromethylphenyl)-3-
picoline 
4CF3 7l 64 
4-(2-nitrophenyl)-3-
picoline 
 
2NO2 7m 39 
4-(3-nitrophenyl)-3-
picoline 
 
3NO2 7n 70 
4-(4-nitrophenyl)-3-
picoline 
 
4NO2 7o 79 
4-(2-cyanophenyl)-3-
picoline 
2CN 7p 42 
4-(3-cyanophenyl)-3-
picoline 
3CN 7q 87 
4-(4-cyanophenyl)-3-
picoline 
4CN 7r 68 
Compound Substituent Designation Yield (in nearest 
whole number %) 
4-phenyl-3,5-lutidine 
 
H 12a 65 
4-(2-methylphenyl)-3,5-
lutidine 
2CH3 12b 49 
4-(3-methylphenyl)-3,5-
lutidine 
3CH3 12c 45 
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Table 6: Isolated yields of 4-aryl-3,5-lutidines 
 
 
Since 12j and 12m could not be obtained using the aforementioned SM coupling conditions, 
we decided to pursue an alternate synthetic route. As shown in Scheme 8, this route 
involved the aldol condensation of 2-trifluoromethyl or 2-nitro benzaldehyde with propanal 
followed by reaction of the resulting cinnamaldehyde product with propanal and an 
ammonium salt to generate a 1,4-dihydropyridine species which could be oxidised to furnish 
12j and 12m. 
4-(4-methylphenyl)-3,5-
lutidine 
4CH3 12d 36 
4-(2,4-dimethylphenyl)-
3,5-lutidine 
2CH3+4CH3 12e 54 
4-(2-methoxyphenyl)-3,5-
lutidine 
2OCH3 12f 47 
4-(3-methoxyphenyl)-3,5-
lutidine 
3OCH3 12g 49 
4-(4-methoxyphenyl)-3,5-
lutidine 
4OCH3 12h 56 
4-(2,4-dimethoxyphenyl)-
3,5-lutidine 
2OCH3+4OCH3 12i 54 
4-(2-
trifluoromethylphenyl)-
3,5-lutidine 
2CF3 12j 0 
4-(3-
trifluoromethylphenyl)-
3,5-lutidine 
3CF3 12k 45 
4-(4-
trifluoromethylphenyl)-
3,5-lutidine 
4CF3 12l 58 
4-(2-nitrophenyl)-3,5-
lutidine 
2NO2 12m 0 
4-(3-nitrophenyl)-3,5-
lutidine 
3NO2 12n 53 
4-(4-nitrophenyl)-3,5-
lutidine 
4NO2 12o 42 
4-(2-cyanophenyl)-3,5-
lutidine 
2CN 12p 12 
4-(3-cyanophenyl)-3,5-
lutidine 
3CN 12q 60 
4-(4-cyanophenyl)-3,5-
lutidine 
4CN 12r 60 
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Scheme 8: Proposed synthetic route to 12j and 12m 
The aldol condensation between propanal and both 2-trifluoromethylbenzaldehyde and 2-
nitrobenzaldehyde produced, under various conditions, a thick gel from which no product 
could be isolated. We also attempted the addition of propanal enolate, generated by kinetic 
deprotonation of propanal, to the benzaldehyde moieties. Disappointingly, this reaction only 
gave a mixture of multiple products which could not be purified by chromatography. In both 
cases only significant amounts of the 2-substituted benzaldehyde substrate could be 
separated from the reaction mixture. Due to the failure of the first step of our proposed 
synthetic route, compounds 12j and 12m have thus far not been isolated. 
The 58 4-aryl-pyridine moieties we obtained in the manner described above were 
characterized based on 1H, 13C, DEPT 135 and, where applicable, 19F NMR spectra, High 
Resolution Mass Spectrometry (HRMS), and Infrared (IR) Spectra. Uncorrected melting points 
are reported for the solid compounds and where possible crystal structures have been 
collected.  
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MEASUREMENT OF ACID DISSOCIATION CONSTANTS 
 
The acid dissociation constants (Ka’s) of the conjugate acids of 1a-x, 7a-r and- with the 
exception of 12j and 12m- 12a-r - were measured by UV-visible spectrophotometry. These 
compounds were all insoluble in water and a suitable solvent system first had to be chosen. 
Surmising that 12e was likely to be the most lipophilic compound in our library, we 
attempted preparation of a 10-3 mol dm-3 solution of 12e in various acetonitrile-water 
mixtures. A 50% solution of water in acetonitrile was found to be the most aqueous solvent 
system that could yield a 10-3 mol dm-3 solution of 12e and all Ka’s were therefore measured 
in a 1:1 mixture of acetonitrile and water. 
With the solvent system established, UV-visible absorbances of the compounds in our 
library (analytes) were mapped within a 200-800 nanometre interval in both strongly acidic 
and strongly basic media at 25oC by mixing equal volumes of a 5X10-5 – 3X10-4 mol dm-3 
solution of the analyte in acetonitrile with a 0.1 mol dm-3 aqueous solution of HCl or KOH. 
The absorbance in HCl solution corresponds to the absorbance of the protonated form of 
the analyte (Amax) occurring at wavelength λmax, while the absorbance in KOH solution 
corresponds to absorbance of the neutral form of the analyte (Amin) at wavelength λmin. For 
the first few compounds tested in such a manner, absorbances were additionally measured 
over a range of pH’s to check for the appearance of an isosbestic point (Figure 17), which 
would indicate the presence of only two absorbing species (the base and its conjugate acid). 
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Figure 17: Absorbance v Wavelength plot 
 
From these absorbance measurements, an analytical wavelength- λobs- was chosen such that 
the difference between Amax and Amin was maximum at this wavelength. The absorbance of 
the analyte at λobs (Aobs) was then measured over a pH range at 25oC to obtain a plot of Aobs 
versus pH. (Aobs versus pH values can be found in the Compact Disk accompanying this 
manuscript) 
λmax, λmin, λobs, and concentration of the analytes used for measurement of pKa values are 
given below in Tables 7,8,9. All wavelengths are expressed in nanometres (nm), and 
concentrations are expressed in 10-6 moles dm-3 (µM). 
UV-vis Absorbance data for 4-Aryl pyridines: 
Compound Substituent λmax  λmin λobs Analyte 
Concentration 
Pyridine --- 256 
 
257 254 200 
1a H 288 
 
255 
 
300 100 
1b 2CH3 283 248 296 100 
1c 3CH3 290 258 293 50 
1d 4CH3 303 265 303 100 
1e 2CH3+4CH3 299 257 303 100 
1f 2OCH3 333 295 333 200 
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1g 3OCH3 285 258 291 100 
1h 4OCH3 328 280 328 50 
1i 2OCH3+4OCH3 346 298 346 75 
1j 2CF3 258 260 258 150 
1k 3CF3 272 248 285 75 
1l 4CF3 271 249 282 75 
1m 2NO2 247 256 252 150 
1n 3NO2 266 245 283 50 
1o 4NO2 284 286 284 50 
1p 2CN 268 245 273 100 
1q 3CN 271 250 281 50 
1r 4CN 276 261 296 100 
1s 2CH2OH 278 246 278 75 
1t 4CH2OH 297 261 297 100 
1u 2CHO 243 255 244 100 
1v 4CHO 286 275 305 100 
1w 2CO2CH3 263 215 274 150 
1x 4CO2CH3 281 265 293 50 
Table 7: Absorbance versus wavelength data for 4-aryl pyridines 
 
 
UV-vis Absorbance data for 4-Aryl-3-picolines: 
Compound Substituent λmax λmin λmax Analyte 
Concentration 
1a H 271 
  
242 
 
286 100 
1b 2CH3 264 208 266 100 
1c 3CH3 272 245 286 200 
1d 4CH3 292 251 303 100 
1e 2CH3+4CH3 290 251 290 50 
1f 2OCH3 314 271 313 200 
1g 3OCH3 270 246 273 50 
1h 4OCH3 314 266 314 100 
1i 2OCH3+4OCH3 328 266 328 200 
1j 2CF3 263 263 263 100 
1k 3CF3 265 235 265 75 
1l 4CF3 264 236 264 100 
1m 2NO2 264 263 264 50 
1n 3NO2 262 232 263 50 
1o 4NO2 273 277 267 50 
1p 2CN 266 268 267 200 
1q 3CN 265 214 265 75 
1r 4CN 266 246 272 75 
Table 8: Absorbance versus wavelength data for 4-aryl-3-picolines 
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UV-vis Absorbance data for 4-Aryl-3,5-lutidines: 
Compound Substituent λmax λmin λmax Analyte 
Concentration 
1a H 267 
 
267 
 
267 200 
1b 2CH3 267 265 268 200 
1c 3CH3 270 266 278 200 
1d 4CH3 271 243 280 200 
1e 2CH3+4CH3 268 266 271 200 
1f 2OCH3 270 273 268 250 
1g 3OCH3 269 273 262 200 
1h 4OCH3 304 265 304 200 
1i 2OCH3+4OCH3 324 274 321 300 
1j 2CF3 --- --- --- --- 
1k 3CF3 267 267 267 200 
1l 4CF3 267 267 267 150 
1m 2NO2 --- --- --- --- 
1n 3NO2 265 267 262 75 
1o 4NO2 270 270 270 50 
1p 2CN 270 270 270 200 
1q 3CN 267 267 266 200 
1r 4CN 266 267 366 100 
Table 9: Absorbance versus wavelength data for 4-aryl-3,5-lutidines 
 
Least squares fitting of this plot to Equation 2 gave a value for Ka along with the associated 
error.  
 
 
The negative logarithms of the Ka values (pKa’s) so obtained are given below in Tables 10-12. 
In addition to the pKa values of the 58 compounds we had synthesized, we also measured 
the pKa of the conjugate acid of pyridine in both water and 1:1 acetonitrile-water mixture to 
check the accuracy of our spectrophotometric method as well as the effect of solvent on the 
pKa values. 
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pKa values for 4-Aryl pyridines: 
Compound Substituent pKa 
Pyridine (aqueous) --- 5.20±0.03 
Pyridine (1:1::acetonitrile:water) --- 3.59±0.03 
1a H 3.51±0.05 
1b 2CH3 3.34±0.05 
1c 3CH3 3.54±0.05 
1d 4CH3 3.70±0.04 
1e 2CH3+4CH3 3.46±0.04 
1f 2OCH3 3.62±0.06 
1g 3OCH3 3.41±0.04 
1h 4OCH3 3.84±0.04 
1i 2OCH3+4OCH3 3.97±0.03 
1j 2CF3 2.71±0.03 
1k 3CF3 2.93±0.05 
1l 4CF3 2.94±0.04 
1m 2NO2 2.67±0.06 
1n 3NO2 2.78±0.03 
1o 4NO2 2.69±0.03 
1p 2CN 2.48±0.04 
1q 3CN 2.94±0.04 
1r 4CN 2.87±0.04 
1s 2CH2OH 3.36±0.05 
1t 4CH2OH 3.53±0.04 
1u 2CHO 3.43±0.15 
1v 4CHO 3.02±0.05 
1w 2CO2CH3 3.23±0.03 
1x 4CO2CH3 3.09±0.05 
Table 10: pKa values for 4-aryl pyridines 
 
pKa values for 4-Aryl-3-picolines: 
Compound Substituent pKa 
7a H 3.57±0.04 
7b 2CH3 3.54±0.05 
7c 3CH3 3.60±0.04 
7d 4CH3 3.64±0.04 
7e 2CH3+4CH3 3.58±0.04 
7f 2OCH3 3.64±0.04 
7g 3OCH3 3.62±0.06 
7h 4OCH3 3.73±0.03 
7i 2OCH3+4OCH3 3.81±0.04 
7j 2CF3 3.00±0.04 
7k 3CF3 3.23±0.04 
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7l 4CF3 3.22±0.05 
7m 2NO2 3.06±0.07 
7n 3NO2 3.09±0.05 
7o 4NO2 2.97±0.05 
7p 2CN 2.76±0.04 
7q 3CN 3.14±0.04 
7r 4CN 3.16±0.05 
Table 11: pKa values for 4-aryl-3-picolines 
 
 
pKa values for 4-Aryl-3,5-lutidines: 
Compound Substituent pKa 
12a H 3.90 
12b 2CH3 3.89±0.03 
12c 3CH3 3.94±0.03 
12d 4CH3 3.99±0.03 
12e 2CH3+4CH3 3.96±0.04 
12f 2OCH3 3.99±0.05 
12g 3OCH3 3.87±0.03 
12h 4OCH3 4.00±0.03 
12i 2OCH3+4OCH3 4.01±0.03 
12j 2CF3 --- 
12k 3CF3 3.49±0.04 
12l 4CF3 3.48±0.04 
12m 2NO2 --- 
12n 3NO2 3.40±0.06 
12o 4NO2 3.24±0.18 
12p 2CN 3.10±0.04 
12q 3CN 3.14±0.04 
12r 4CN 3.16±0.05 
Table 12: pKa values for 4-aryl-3,5-lutidines 
 
 
 
 
 
 
 
42 
 
RESULTS AND DISCUSSION 
 
A pKa value of 5.20±0.03 was obtained for pyridine in water, which is in excellent agreement 
with literature values of 5.17 98 and 5.22.96 In a 1:1 mixture of acetonitrile (MeCN) and 
water, we calculated a pKa of 3.59±0.03 for pyridine. This value lies between the previously 
measured 3.88 for pyridine in a 40:60::MeCN:water mixture and 3.00 for pyridine in a 
60:40::MeCN:water mixture based on buffers which were calibrated in water.97 As 
demonstrated by Bosch and Rosés, this decrease in pKa is partly due to a difference between 
solvation effect of water and the MeCN-water mixture as well as change in buffer activity on 
moving from water to a mixed solvent system.97 Since our procedure involves preparation 
and calibration of buffer solutions in water, the pKa value of pyridine in 1:1 MeCN-water 
mixture reported herein will be lower than those reported by other authors who have 
calibrated buffers in MeCN-water mixtures.98  
The pKa obtained for 4-phenyl-pyridine- 3.51±0.05 -is marginally lower than that of pyridine 
in 1:1 MeCN-water mixture. Using Equation 4, we can deduce that the free energy change 
produced by deprotonating the conjugate acid of 4-phenyl-pyridine in 1:1 MeCN-water 
mixture at 25oC  is, to the first decimal place, +20.0±0.3 kJ/mol. To facilitate a discussion of 
substituent effects on pKa, this value can be used to introduce the parameter dΔG. Here, 
dΔG is defined as the difference between the free energy change produced by 
deprotonation of the conjugate acid of a reference base in a 1:1 MeCN-water mixture at 
25oC and the free energy change produced by deprotonation of the conjugate acid of a base 
containing a particular substituent under the same conditions.  
Mathematically, dΔG can be expressed using Equation 5. By definition, a negative value of 
dΔG indicates an increase in basicity of the compound containing the relevant substituent 
relative to the reference base while a positive value of dΔG implies a decrease in basicity 
relative to the reference base. 
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As mentioned in the previous section, the conventional indicator of substituent effects has 
been the Hammett constant σ. Mathematically, σ is expressed using Equation 6 81. As seen 
from Equation 6, σ is a dimensionless quantity that is related to dΔG by Equation 7.  
 
σ = log(KaX) - log(KaH) = pKaH - pKaX    (Equation 6) 
                                        
                                        dΔG = 2.303RTσ    (Equation 7) 
Since both rotational barrier and ground state geometry of biphenyls are temperature 
dependant85, we have elected here to quantify substituent effects using the temperature 
dependant quantity dΔG. Furthermore, since pKa’s have been measured at 298K, the 
numerical value of σ is attenuated by a factor of 5.7 relative to dΔG, which could lead to small 
substituent effects expressed in terms of σ values being overlooked.  
 
For compounds 1a-x 4-phenyl-pyridine (1a) is chosen as the reference base. For compounds 
7a-r the reference base is 4-phenyl-3-picoline (7a) and for compounds 12a-r, 4-phenyl-3,5-
lutidine (12a) is selected as the reference base. Thus, comparison of dΔG values for a 
particular substituent across the pyridine, picoline and lutidine series can elucidate the effect 
of increasing steric bulk in the flanking ortho position (presumably leading to an increased 
torsional angle) on the effect of that substituent. Comparison of dΔG values within a series 
provides the relative magnitude of a substituent effect based upon position and nature of the 
substituent. dΔG values for the pyridine series (denoted dΔG Py), picoline series (denoted dΔG 
Pi) and lutidine series (denoted dΔG Lu) are shown in Table 13. The substituents are designated 
by a numerical prefix which indicates the position of the substituent on the phenyl ring (Figure 
12) along with the molecular formula of the substituent. The error in calculating dΔG values 
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is derived from the standard error propagation formula shown in Equation 8. dΔG values that 
are smaller than the associated error are considered negligible.  
 
 
 
Figure 18: Labelled substituent positions 
Entry Substituent (X) dΔG Py dΔG Pi dΔG Lu 
1 H 0.0±0.0† 0.0±0.0† 0.0±0.0† 
2 2CH3 1.0±0.4 Negligible Negligible 
3 3CH3 Negligible Negligible Negligible 
4 4CH3 -1.0±0.4 -0.4±0.3 Negligible 
5 2CH3+4CH3 Negligible Negligible Negligible 
6 2OCH3 -0.6±0.4 -0.4±0.3 Negligible 
7 3OCH3 Negligible Negligible Negligible 
8 4OCH3 -1.9±0.3 -0.9±0.3 Negligible 
9 2OCH3+4OCH3 -2.6±0.3 -1.4±0.3 -0.4±0.3 
10 2CF3 4.6±0.3 3.3±0.3 --- 
11 3CF3 3.3±0.4 1.9±0.3 2.5±0.4 
12 4CF3 3.2±0.3 2.0±0.4 2.6±0.4 
13 2NO2 4.8±0.4 2.9±0.4 --- 
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14 3NO2 4.2±0.3 2.7±0.3 3.1±0.5 
15 4NO2 4.7±0.7 3.4±0.5 4.0±1.1 
16 2CN 5.9±0.3 4.6±0.3 4.8±0.4 
17 3CN 3.3±0.3 2.4±0.3 2.9±0.4 
18 4CN 3.7±0.3 2.3±0.3 2.7±0.4 
19 2CH2OH 0.9±0.4 --- --- 
20 4CH2OH Negligible --- --- 
23 2CHO Negligible --- --- 
24 4CHO 2.8±0.4 --- --- 
25 2CO2CH3 1.7 --- --- 
26 4CO2CH3 2.4±0.4 --- --- 
        †: by definition 
Table 13: dΔG values for compounds with measured pKa values 
 
A discussion of substituent effects on pKa must begin by examining the mode of transmission 
of substituent effects. Inductive effects, which are produced by substituent induced 
polarization of covalent sigma bonds, decay exponentially with each intervening bond.99 A 
direct inductive effect by the substituent on the nitrogen atom of the 4-aryl-pyridine species 
is therefore likely to be insignificant since there are 6-8 intervening bonds.  
Campanelli and Domenicano have conducted an in-silico investigation on the transmission of 
substituent effects in 4-substituted biphenyls.100  
 
 
 
Figure 19: Biphenyl conformations studied by Campanelli et al. 
 
The salient points from this investigation are noteworthy here: 
 
i) In an orthogonal conformation (Figure 19a), where the torsional angle between 
rings A and B is 90o, no resonance interactions between A and B are present. The 
substituent X polarizes the π cloud of ring A, producing different π charges at each 
position of ring A. This polarization of the π cloud in ring A causes a field effect 
upon ring B. In cases where X produces a mesomeric effect on ring A, the partial π 
charges at positions ortho and para to X are further modified due to resonance, in 
turn modifying the field effect upon ring B.   
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ii) In a coplanar configuration (Figure 19b), where the torsional angle between A 
and B is zero, both resonance and field effects influence ring B. Substituents that 
exert a mesomeric effect on ring A influence the distribution of electron density 
between A and B via resonance.  Substituents that do not have a mesomeric 
effect on ring A still affect the resonance between A and B by polarizing the π 
cloud of A.  
Additionally, a study of substituent effects on C13 NMR shifts in 4-substituted biphenyls by 
Schulman et al. suggests that the mesomeric effect of the substituent predominantly affects 
C13 NMR shifts.101  Based on these reports and the fact that the torsional angle in the pyridine, 
picoline and lutidine probes is between 0o and 90o, it can be expected that substituent effects 
on the pKa’s of these probes will be due to a combination of resonance and field effects, with 
the relative importance of each effect depending upon the torsional angle between the 
phenyl and pyridyl ring. The calculations of Campanelli et al. suggest that in 4-substituted 
biphenyls (Figure 19a&b), π charges meta to the substituent X appear to have the largest 
effect on ring B, with the field effect on B due to π charges at the ortho and para positions 
(relative to X) being approximately equal.100 Considering the fact that there are twice as many 
ortho positions as para, it would seem that partial π charges on ring A that are in greater 
proximity to ring B produce a greater field effect. While it is yet unknown whether a similar 
trend is valid for 2 and 3-substituted biphenyls, this assumption suggests that 2-substituents 
would exert a more powerful field effect than substituents in the 3 or 4 position. 
A discussion of substituent effects based on the interpretation of dΔG values is given below: 
 
Electron Withdrawing Substituents (dΔG >0): 
9 crystal structures have been obtained which indicate that the torsional angles in compounds 
1a-x, 7a-r and 12a-r lie between 0o and 90o. While the torsional angles in these compounds 
may be different in solution, it is nevertheless likely that these compounds exist, in the ground 
state, in a conformation that is neither orthogonal nor coplanar. The effects of an electron 
withdrawing substituent are thus expected to be transmitted via: 
i) Resonance interactions between the phenyl and pyridyl ring which is influenced 
by the lowering of π-electron density on the phenyl ring due to the substituent. 
ii) Field effects on the pyridyl ring due to polarization of the phenyl ring’s π-cloud by 
the substituent. 
iii) Substituents with π-acceptor orbitals, such as the nitro group (NO2) and the cyano 
group (CN), when in the 2 and/or 4 position, could possibly exert a mesomeric 
effect on the pyridyl ring. Figure 20 shows the dependence of the substituent’s 
mesomeric effect on its position: for 3-substituents, electron withdrawal due to 
resonance (denoted by δ+) with the substituent is confined to the phenyl ring. 4-
substituents on the other hand exert a mesomeric effect on both phenyl and 
pyridyl rings.  
 
47 
 
 
Figure 20: Dichotomy between mesomeric effects of 3 substituents and 2/4 substituents 
From the dΔG values for the trifluoromethyl (CF3), CN and NO2 substituted probes, it is evident 
that the total effect of these substituents is, in the 3 position, very similar to their effect in 
the 4-position. In the case of CN and NO2 substituents, it is possible that the mesomeric 
interaction between the substituents in the 4 position is compensated for by a larger field 
effect in the 3-substituted compounds. However, the CF3 group is not known to exert a 
mesomeric effect and the dΔGPy, dΔGPi, and dΔGLu values for 3-CF3 and 4-CF3 indicate that the 
field effects exerted by 3 and 4 substituents are similar in magnitude. This implies that the 
difference between resonance interactions in 3-substituted probes and 4-substituted probes 
is small and that mesomeric interactions between the substituent and the pyridyl ring 
(discussed above in Point iii) are not significant.  
Overall, resonance between the phenyl and pyridyl rings appears to have a significant effect 
on pKa, based on the decrease in dΔG values for the CF3, CN and NO2 substituents on going 
from the pyridine series to the picoline and lutidine series.  
The CF3 and CN substituents have larger dΔG values in the 2 positon than in the 3 or 4 
positions. Since the CF3 group does not exhibit a mesomeric effect, this trend must result from 
a field effect. Campanelli et al. have calculated the partial π-charges that result from 
polarization of the phenyl π-cloud due to a substituent. According to these calculations, CF3, 
CN and NO2 groups induce the largest positive π-charges at positions ortho to the 
substituent.100 Based on this result, the largest charges induced by the 2-substituent should 
occur at positions 1 and 3 (numbering of positions shown in Figure 18) while the 3-substituent 
and 4-substituent should induce the largest π-charges in positions 2 and 4 and 3 and 3 
respectively. The relatively large dΔG values for 2-substituents therefore support the 
assumption that π-charges in greater proximity to the pyridyl ring produce a greater field 
effect.  
Unlike the CF3 and CN groups, the 2-NO2 substituent has dΔG values similar to the 3-NO2 and 
4-NO2 substituents. The crystal structure of 1m (Figure 21) provides a likely explanation for 
this trend. 
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Figure 21: 4-(2-nitrophenyl)-pyridine crystal structure 
The NO2 group in the crystal structure above is twisted approximately 40o out of the plane 
of the phenyl ring. This would lead to reduced conjugation with the phenyl ring, leading to 
smaller π-charges on the phenyl ring on account of the twisted NO2 substituent exerting a 
decreased mesomeric effect. The smaller π-charges on the phenyl ring are likely to reduce 
both field and resonance interactions with the pyridyl ring. The smaller than expected dΔG 
value for the 2-NO2 substituent can thus be explained by the reduced electron withdrawing 
capability of the NO2 group when twisted out of the plane of the phenyl ring. In support of 
this thesis, the crystal structures of compounds 1n (Figure 22) and 12n (Figure 23) show the 
3-NO2 group to be approximately in the plane of the phenyl ring. 
 
Figure 22: 4-(3-nitrophenyl)-pyridine crystal structure 
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Figure 23: 4-(3-nitrophenyl)-3,5-lutidine crystal structure 
The cyano group in the 2 position produces the largest substituent effect amongst all the 
substituents tested. However, in the 3 and 4 position its effects are similar to those of the CF3 
group in the 3 and 4 position, implying the large dΔG values for the 2-CN substituent do not 
stem from greater mesomeric or field effects. We hypothesized that the strong substituent 
effects for the CN group might be due to secondary electronic effects. The cyano group has 
two mutually perpendicular, vacant, anti-bonding π* orbitals. If one of these π* orbitals is 
assumed to overlap with the π system of the phenyl ring (by being perpendicular to the plane 
of the phenyl ring), the second π* orbital might be in a favourable orientation for overlap with 
the π system of the pyridyl ring. Figure 24 depicts the hypothesized interaction between the 
cyano group and the pyridyl ring: The shaded π* lobes are in the plane of the phenyl ring 
while the light π* lobes are perpendicular to the phenyl ring.  
 
Figure 24: Depiction of hypothesized interaction between pyridyl ring and cyano groups 
This π -π* interaction between the pyridyl ring and the cyano group, we reasoned, would 
decrease electron density over the pyridyl system, thereby contributing to a lower pKa. 
Precedent for donation into the π* orbitals of the cyano group exists in the form of 
organometallic complexes of nitriles, which have been shown to exhibit electron donation by 
the metal into the π* orbital of the cyano group.102 Furthermore, the crystal structure of 1p 
(Figure 25), reveals the distance between the carbon atom of the cyano group and the nearest 
π-bond in the pyridyl ring to  be in the 2.9-3 Å range - a range in which non-covalent 
interactions such as halogen bonding are known to occur.103  
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Figure 25: 4-(2-cyanophenyl)-pyridine crystal structure 
 
To test the presence of this secondary electronic effect, we synthesized compounds 1u-x. 
These compounds contain the formyl or carbomethoxy functional group, both of which 
possess a single π* anti-bonding orbital. A significant pyridyl π-carbonyl π* interaction 
would require the carbonyl functionality of these two substituents to twist out of 
conjugation with the phenyl ring (Figure 26) and we reasoned that such twisting might be 
detectable from the IR specta, pKa values and X-ray structures of these compounds. 
 
Figure 26: Depiction of hypothesized interaction between pyridyl ring and carbonyl group 
 
The formyl group (CHO) was found to have negligible effect on pKa in the 2 position. A large 
error was also associated with the measured pKa of compound 1u. This error is due to the 
deviation of Aobs from expected values at lower pH’s, possibly due to the existence of an 
aldehyde-hydrate equilibrium which is shifted with change in pH. In the 4-position, the CHO 
group was found to have a relatively weak electron withdrawing effect. The carbomethoxy 
group (CO2CH3) was found to exert a stronger effect in the 4-position than in the 2-position, 
which is opposite to the trend followed by CF3, CN and NO2 substituents as well as the 
opposite of what would be expected in the case of significant  carbomethoxy π*-pyridyl π 
interaction. 
The IR spectra of compounds containing carbonyl groups show a strong absorption band in 
the 1600-1850 cm-1 range.104 When attached to an electronic donating group, the carbonyl 
band is shifted to lower frequencies (or lower wave numbers).105 Conjugation of the carbonyl 
functionality with an aryl ring thus results in the C=O stretch in aromatic carbonyl compounds 
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occurring at lower wave numbers than aliphatic carbonyl compounds.104 It would therefore 
be expected that twisting of the carbonyl group in compounds 1u and 1w out of conjugation 
with the phenyl ring would result in shifting of the C=O band to a higher frequency. The C=O 
bands in the IR spectra of 1u occur at 1692 cm-1. The IR spectrum of 1v contains closely 
overlapping bands at 1694 and 1680 cm-1. In compounds 1w and 1x, the C=O bands occur at 
1721 and 1717 cm-1 respectively. The appearance of the C=O band at a marginally higher 
frequency in 1w than in 1u rules out significant twisting of the formyl group out of conjugation 
with the phenyl ring, as supported by the crystal structure of 1u (Figure 27). As seen below, 
the formyl group in the crystal structure of 1u is twisted out of plane by a very small 8o angle 
 
Figure 27: 4-(2-carbomethoxyphenyl)-pyridine crystal structure 
 
While the C=O band in 1w does appear at a slightly higher frequency than in 1x, the dΔGPy 
values for the CO2CH3 substituent are not consistent with the carbomethoxy π*-pyridyl π 
interaction hypothesis. Based on the trend in dΔGPy values for the CO2CH3 substituent and the 
NO2 substituent, it appears that the steric hindrance imposed by the CO2CH3 substituent in 
the 2 position either forces a larger torsional angle or causes the carbomethoxy to be twisted 
slightly out of conjugation with the phenyl ring. In both cases, electron withdrawal from the 
pyridyl ring due to resonance is reduced, leading to smaller dΔGPy values for the CO2CH3 
substituent in the 2 position than in the 4 position. By the same rationale, the small size of 
the cyano group allows a smaller torsional angle, which should enhance the resonance 
between the phenyl and pyridyl rings. It therefore is possible that the larger dΔG values for 
the 2-CN substituent compared to the 2-CF3 substituent is due to the different sizes of the 
two substituents. This is corroborated by the crystal structure of 1p (Figure 25), that shows 
the torsional angle to be approximately 42o, which is smaller than the 45o torsional angle for 
biphenyl and the 60o torsional angle for compound 1f (See Figure 28 below). 
It is also possible, however that the orientation of the π* orbital in the C=O groups of 1u, 1v, 
1w and 1x precludes interaction with the π orbital of the pyridyl ring, which is not the case 
with the CN group which possesses two mutually perpendicular π* orbitals. Further 
examination of the unexpectedly large dΔG values for the 2-CN substituent is therefore 
required. A functionalised alkyne group, which also possesses mutually perpendicular π* 
orbitals, might serve as a useful probe in this context.  
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Electron Donating Substituents (dΔG<0): 
 
 The dΔG py value for the 2-CH3 substituent (Entry 2, Table 13) indicates a lower basicity for 
1b relative to the reference compound 1a. This effect is contradictory to the generally 
accepted assumption that methyl groups have a net electron donating effect, as deduced 
from the Hammett sigma constants for example.81 According to the calculations of 
Campanelli et al., the phenyl ring has a net electron donating effect when it is coplanar to 
the aryl system to which it is attached.100 The methyl group in the 2 position is likely to 
increase the torsional angle between the phenyl and pyridyl ring on account of its greater 
steric bulk (relative to hydrogen)106, which would decrease or eliminate any resonance 
generated net electron transfer from the phenyl ring to the pyridyl ring. The disappearance 
of the 2-methyl substituent effect in the picoline and lutidine series supports this thesis, 
since any electron donation by the phenyl ring in reference compounds 7a and 12a would 
already be weakened or eliminated by the increase in torsional angle caused by the methyl 
substituent(s) on the pyridine ring.  
A comparison of dΔGpy values for the 3-CH3 and 4-CH3 substituent shows a net electron 
donating effect for the 4-CH3 substituent but a negligible effect for the 3-CH3 substituent. 
The same trend is observed for the 3-OCH3 and 4-OCH3 substituents. This is contrary to the 
substituent effects seen in the case of electron withdrawing groups. As discussed previously, 
electron withdrawing groups did not appear to exert a direct mesomeric effect on the 
pyridyl ring. However, the methyl and the methoxy groups only seem to affect the pyridyl 
ring when in the 2 and/or 4 position, which indicates a mesomeric interaction between the 
pyridyl ring and the substituent. It is currently unclear as to why this dichotomy between 
electron donating and electron withdrawing substituents exists. 
If a mesomeric interaction between electron donating substituents and the pyridyl ring is 
assumed, the dΔGpy values of the methyl group can be explained by hyperconjugation. 
Electron donation by hyperconjugation is consistent with the disappearance of the 
substituent effect in the picoline and lutidine series (due to the increased torsional angle 
and reduced resonance in the picoline and lutidine compounds) as well as the negligible 
dΔGpy value for the 3-CH3 substituent. The lack of a significant difference between the 13C 
chemical shifts of the benzylic carbon in 1c and 1d- as would be expected in the case of 
mesomeric interaction between the benzylic carbon and phenyl ring107 - does not rule out a 
hyperconjugative effect given the small magnitude of dΔGpy for the 4-CH3 substituent. For 
comparison, the protonation of 4-bromo-3-picoline- which would presumably produce a 
free energy change an order of magnitude larger than dΔGpy for the 4-methyl substituent- 
causes the 13C chemical shift of the benzylic proton to vary by only 0.78 ppm.  
The lack of an observable substituent effect in the case of 2,4-dimethyl substitution (Entry 5, 
Table 13) can again be explained by increase in torsional angle between the pyridyl and 
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phenyl rings due to the 2-CH3 group which would reduce hyperconjugation induced electron 
donation. 
Substituent effects due to the methoxy group follow the same pattern seen for the methyl 
group with the exception that the 2-OCH3 substituent has a small electron donating effect 
and the 3-OCH3 substituent has a weak electron withdrawing effect. Again, a mesomeric 
interaction between the methoxy group and the pyridyl ring can be invoked to explain the 
observed dΔG values. While the mesomeric effect of the 3-OCH3 substituent will be confined 
to the phenyl ring, the electron withdrawing field effect of the methoxy group – as indicated 
by the positive Hammett constant for the methoxy group in the meta position – will lead to 
a slight decrease in electron density on the pyridyl ring. Although the 2-OCH3 and 4-OCH3 
substituent both exert a mesomeric effect on the pyridyl ring, the crystal structure of 
compound 1f (Figure 28) reveals the torsional angle to be 60o- which is larger than that 
observed in biphenyl or in the case of 1p. The mesomeric effect of the methoxy group on 
the pyridyl ring is presumably weakened in 1f due to a larger torsional angle, leading to a 
greater dΔGpy value for the 4-OCH3 substituent. As expected from a resonance transmitted 
effect, the substituent effects of the methoxy group decrease on going from to pyridine 
series to the picoline and lutidine series. The relation between dΔGPy values for the 2,4-
dimethoxy substituent and the 2-OCH3 and 4-OCH3 substituents appears to be 
approximately additive. The small, negative dΔGLu value for the 2,4-dimethoxy substituent 
possibly stems from the combined mesomeric effect of 2 methoxy groups, while the effect 
of a single methoxy group in the lutidine is below detection limits. 
 
 
Figure 28: 4-(2-methoxyphenyl)-pyridine crystal structure 
 
The chalcogen elements oxygen and sulphur have been observed to preferentially interact 
with the edges of aromatic rings.108 Hypothesizing that such interactions might affect the 
torsional angles in the 4-aryl-pyridine species, we synthesized compounds 1s and 1t. We 
reasoned that interaction between the oxygen atom and the edge of the pyridinyl ring might 
lead to interaction between the π* anti-bonding orbitals of the pyridine and the lone pair of 
electrons on the oxygen atom (Figure 29), causing an increase in pKa. 
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Figure 29: Depiction of hypothesized interaction between hydroxyl group and pyridyl ring 
in 4-(2-hydroxymethylphenyl)-pyridine 
The dΔGpy value for the hydroxymethyl (CH2OH) substituent in the 2-position is close to that 
observed for the 2-CH3 substituent, indicating a similar steric effect that reduces electron 
donation from the phenyl ring to the pyridyl ring. The dΔGpy value for the 4-CH2OH substituent 
is negligible, as opposed to the small negative value for the 4-CH3 substituent. This is possibly 
due to the lack of a significant hyperconjugative effect caused by the electronegative oxygen 
atom. Accordingly, we can conclude that in the case of the hydroxymethyl group, no 
secondary electronic effects are detectable. 
 
Substituent effects on rotational barriers: 
The barrier to rotation in biphenyl species depends upon the difference between the energy 
of the molecule in the ground state and the energy of the transition state (TS) the molecule 
must go through in order to complete one rotation. Multiple computational studies57,63,70 
suggest that the TS involved in rotation about the sigma bond linker in biphenyl compounds 
possesses a near-planar or planar geometry (i.e a geometry in which the torsional angle 
between the two aryl rings is 0o, as shown in Figure 19b). According to the calculations of 
Campanelli et al., in a planar geometry, both electron withdrawing and electron donating 
groups enhance resonance interactions between the two aryl rings.100 While non-resonant 
substituents affect resonance between the aryl rings through the induction of partial π-
charges, substituents with π-acceptor or π-donating orbitals affect resonance through 
mesomeric effects as well as π-charge generation.100 The substituent induced enhanced 
exchange of electron density between the two rings also leads to shortening of the sigma 
bond linker, which increases steric repulsions between the ortho substituents.100 Thus, in the 
planar TS, the stabilization brought about by the substituent via enhanced resonance 
between the aryl rings is offset by an increase in steric repulsions between the ortho 
substituents.   
According to the model described above, a biphenyl compound with an electron donating 
group on one of the rings and an electron withdrawing group on the other ring (i.e push-pull 
substitution) could lower the energy of the planar TS due to enhanced resonance 
stabilization.62 Provided the groups in the ortho positions do not enforce a steric barrier large 
enough to preclude significant resonance stabilization of the TS, such push-pull substitution 
could result in lowering of the rotational barrier. Data published by Konig et al. on the 
55 
 
atropisomerization barriers (ΔracG) of various 4,4’-disubstituted-2,2’-bis(trifluoromethyl)-
biphenyl compounds (Figure 30) shows that this is indeed the case for certain compounds. As 
shown in Entry 10, Table 14, the push-pull substitution pattern in 4-methoxy-4’-nitro-2,2’-
bis(trifluoromethyl)-biphenyl leads to a lower atropisomerisation barrier relative to 2,2’-
bis(trifluoromethyl)-biphenyl (Entry 1, Table 14).  
 
 
Figure 23: 4,4’-disubstituted-2,2’-bis(trifluoromethyl)-biphenyl moiety studied by Konig et 
al. 
 
Entry Designation Y X ΔracG 
(kJ/mol) 
1 13a H H 107.0 
2 13b H OCH3 104.2 
3 13c H NH2 101.7 
4 13d OCH3 OCH3 102.4 
5 13e NH2 NH2 99.7 
6 13f H CF3 106.7 
7 13g H NO2 107.7 
8 13h CF3 CF3 107.6 
9 13i NO2 NO2 109.7 
10 13j OCH3 NO2 103.7 
Table 14: Atropisomerisation barriers of certain 4,4’-disubstituted-2,2’-bis(trifluoromethyl)-
biphenyl moieties (Konig et al.) 
While the model based on Campanelli and Domenicano’s calculations correctly predicts the 
lowering of ΔracG for 13j relative to 13a, it does not readily provide a rationalization for the 
lowering of ΔracG due to electron donating substituents and the increase in ΔracG due to 
electron withdrawing substituents.  
Based on ab-initio calculations of the biphenyl structure, Wu and Mo have postulated that a 
σ-π* interaction between the sigma bonds connecting the ortho hydrogens to the phenyl 
ring (shown in bold in Figure 31) and the π* orbital of the adjacent phenyl ring (depicted as 
a vacant pair of lobes in Figure 31) stabilizes non planar biphenyl conformations.79  
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Figure 31: Depiction of  σ-π* interaction proposed by Wu and Mo 
Since this σ-π* interaction stabilizes non-planar ground state structures, the strengthening of 
this interaction should result in decreasing the energy of the ground state structure and 
consequently increasing the barrier to rotation. Furthermore, since the σ-π* interaction 
involves donation of electron density into the π systems, the interaction will presumably be 
strengthened by electron withdrawing substituents that lower electron density of the π 
system. By the same rationale, electron donating substituents should decrease the strength 
of the σ-π* interaction, thereby decreasing the barrier to rotation.  
Konig et al. have postulated a different theory for explaining the effect of substituents on 
rotational barrier. According to their hypothesis, electron donating groups increase the 
electron density at positions 1 and d (refer to Figure 18), which causes the aryl rings to bend 
out of plane, thereby reducing steric repulsion between the flanking ortho substituents and 
leading to a decrease in energy of the planar conformation. This causes electron donating 
substituents to reduce the rotational barrier.61 Electron withdrawing substituents have the 
opposite effect on the electron density at positions 1 and d and thus lead to an increase in 
the rotational barrier.61 
The atropisomerisation rates shown in Table 14 are consist with both of the aforementioned 
hypotheses - the electron donating NH2 and OCH3 substituents are found to reduce ΔracG 
values while the electron withdrawing NO2 and CF3 groups are observed to have the opposite 
effect. The non-resonant CF3 is also found to have a considerably weaker effect on ΔracG than 
the resonant NO2 group. This may either be due to the NO2 group being a stronger electron 
withdrawing agent (as indicated by the relevant dΔG values in Table 13), or the ability of the 
NO2 group to better stabilize the planar TS by increasing resonance interactions between the 
aryl rings, or a combination of both.  
The ΔracG values for 4,4’-disubstituted-2,2’-diisopropyl-biphenyl compounds (Figure 32) 
determined by Konig et al. follow a trend opposite to the one seen in the case 4,4’-
disubstituted-2,2’-bis(trifluoromethyl)-biphenyls.62  
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Figure 32: 4,4’-disubstituted-2,2’-diisopropyl-biphenyl moiety 
Entry Designation Y X ΔracG 
(kJ/mol) 
1 14a NH2 NH2 115.3 
2 14b NO2 NO2 105.4 
Table 15: Atropisomerisation barriers for certain 4,4’-disubstituted-2,2’-diisopropyl-
biphenyl moieties (Konig et al.) 
Konig et al. have rationalized this result by postulating an attractive interaction between the 
π electrons of the aryl rings and the benzylic proton of the isopropyl group (circled in Figure 
33), which stabilizes the non-planar ground state molecule (Figure 33).62 In this case, the π-H 
interaction is strengthened by increased π electron density in the aryl rings. The electron 
donating NH2 group thus stabilizes the ground state of 14a, increasing its racemisation 
barrier while the NO2 group, which leads to a weaker π-H interaction, results in a lower 
racemization barrier in the case of 14b. 
 
Figure 33: Depiction of benzylic proton-π electron interaction proposed by Konig et al. 
Based on the computational studies of Campanelli et al., Wu et al., and the empirical data 
published by Konig et al., it appears that the rotational barrier in biphenyl compounds is 
governed by a combination of several factors, which are subject to substituent effects in 
varying magnitudes. These include resonance stabilization of the TS, steric repulsion between 
groups in the ortho positions which destabilizes the TS, possible out-of-plane bending of the 
aryl groups, a possible σ-π* interaction, and where applicable, a possible π-H interaction (of 
which the latter two are expected to stabilize the non-planar ground state).  
Given the multiple factors affecting rotational barriers, it is difficult to predict a precise trend 
in rotational barriers based solely upon the data obtained from pKa measurements. However, 
based on data from previous studies, it may be possible to outline a speculative substituent-
rotational barrier relationship.  
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From the dΔGpy values in Table 13, it is clear that in the 3 and 4 position, the effect of the CN, 
CF3 substituents are similar in magnitude, while the NO2 group exerts a stronger effect in the 
same positions. The effect of the 4-CHO substituent is similar in magnitude to the effects of 
the 4-CN and 4-CF3 substituents. Under the assumption that, in the absence of benzylic 
hydrogens (to preclude a π-H interaction), electron withdrawing substituents increase the 
rotational barrier in biphenyl type compounds, the dΔGpy values suggest that the 3-CN, 4-CN 
3-CF3, 4-CF3 and 4-CHO substituents will raise the rotational barrier, but to a lesser extent 
than the NO2 substituent in the 3 or 4 position. By the same rationale, the 4-CO2CH3 
substituent should lead to a smaller increase in the rotational barrier compared to the 
electron withdrawing groups mentioned above. Since the resonant groups CN and NO2 reduce 
the electron density at the 1 and d positions (refer to Figure 18), a larger rotational barrier for 
biphenyl compounds with the 4-CN or 4-NO2 substituent than the analogous biphenyl 
compounds with the 3-CN or 4-NO2 substituent might corroborate the hypothesis of Konig et 
al. regarding out-of-plane bending. 
The negligible dΔGpy value for the 3-CH3 and 4-CH2OH substituents suggests these 
substituents will not have a significant impact on rotational barriers. The more strongly 
electron donating 4CH3 and 4-OCH3 substituents, on the other hand, should lead to decrease 
in the rotational barrier with a greater decrease expected for the methoxy substituent. The 
3-OCH3 substituent exerts a small electron withdrawing effect on the pyridyl ring and, given 
the nature of the mesomeric effect, should not lead to an increase in electron density at the 
1 position (refer to Figure 18). Thus, the lack of a decrease in the rotational barrier due to the 
3-OCH3 substituent should further corroborate Konig’s hypothesis. 
Substitution in the 2 position will include an added steric factor. The relatively bulky CF3 (A 
value = 8.8 kJ/mol85) can be expected to raise the rotational barrier to a greater extent in the 
2 position than in the 3 or 4 positions. This increase may be due to both the steric effect as 
well as the greater electron withdrawing effect, as indicated by the larger dΔGpy value for the 
2-CF3 substituent. While the steric bulk of the CN group is not significantly greater than that 
of hydrogen (A value = 0.9 kJ/mol85), the 2-CN substituent has the largest dΔGpy value amongst 
all substituents tested and this greater electronic effect might therefore lead to a larger 
increase in rotational barrier by the CN substituent in the 2 position than in the 3 or 4 
positions. In the 2 position the NO2 substituent, as mentioned before, is twisted out of the 
plane of the phenyl ring, which is likely to reduce steric repulsion with the flanking ortho 
hydrogen- as indicated by the torsional angle comparable to the torsional angle observed in 
compound 1p. Given the similarity of dΔGpy value for the NO2 group in all three positions and 
the fact that it is twisted out of plane in the 2 position, it is possible that the expected increase 
in rotational barrier due to the NO2 group is similar regardless of its position. The dΔGpy values 
for the CHO and CO2CH3 substituents are both lower in the 2 position than in the 4 position. 
However, the increased steric repulsion between the flanking ortho hydrogen and the 2-CHO 
(A value = 3.3 kJ/mol85) or 2-CO2CH3 substituent (A value = 5.4 kJ/mol85) may be expected to 
compensate for the weaker electronic effect. By this rationale, the CHO and CO2CH3 
substituents should increase the rotational barrier to a similar or greater extent in the 2 
position than in the 4 position. A similar steric argument is applicable for the 2-CH3 (A value = 
7.1 kJ/mol85) and 2-CH2OH (A value ca. 7.1 kJ/mol, based on the A value for the CH3 group and 
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CH2OTs group85) substituents, and these can also be expected to lead to an increase in 
rotational barrier, particularly given their weak electronic effect. The 2-OCH3 substituent 
exerts a relatively weak electron donating effect. However, the expected decrease in 
rotational barrier to the electronic effect of the 2-OCH3 substituent is likely to be 
compensated by the steric repulsion between the flanking ortho hydrogen and the methoxy 
group, as is indicated by the relatively large torsional angle in compound 1f. Thus, the OCH3 
group may lead to a decrease in rotational barrier in the 4-position and either a smaller 
decrease or an increase in rotational barrier in the 2 position.  
The presence of benzylic protons in the picoline and lutidine compounds makes it difficult to 
predict substituent effects on rotational barrier since it is currently not feasible to predict the 
existence or magnitude of π-H or σ- π* interactions in these compounds. Another possibility 
is that the increased steric bulk introduced in the flanking ortho positions by the presence of 
the methyl groups dominates the contribution to the rotational barrier, thereby weakening 
the electronic effect of all substituents.  
In conclusion, we have synthesized and characterised 58 4-aryl pyridine type compounds, 
determined the acid dissociation constants of their conjugate acids in a 1:1 MeCN-water 
solution at 298 K, and obtained crystal structures for compounds 1f, 1m, 1n, 1p, 1u, 7r, 12l, 
12n, 12q and 12r. Using the parameter dΔG to quantify substituent effects, we have observed 
a large substituent effect for the cyano group in the 2 position and a smaller than expected 
substituent effect for the nitro group in the 2 position- which we attribute to the substituent 
being twisted out of the plane of the ring to which it is attached. We now aim to use the data 
produced in this study to guide a computational study aimed at modelling and predicting 
ground state geometries and rotational barriers of substituted biphenyl compounds. 
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SUPPORTING INFORMATION 
 
a) General Information: 
Propanal was twice distilled over anhydrous sodium sulfate and stored under a nitrogen 
atmosphere. Diisopropylamine was distilled over KOH pellets and stored a nitrogen 
atmosphere. Unless specified, all other reagents were obtained from commercial sources 
and used without further purification. Solvents were obtained from Fisher scientific, and 
H2O was deionised before use. HPLC grade acetonitrile from Fischer scientific was used for 
spectrophotometric measurements. 
All 58 aryl-pyridine type compounds were characterised on the basis of NMR, MS, IR, and 
where applicable, XRD experiments. Previously reported compounds were characterised by 
comparison of 1H NMR spectra with those reported in the literature and on the basis of 
subsequent reactions. 
NMR spectra were recorded on a Bruker Avance-400, calibrated to the residual solvent. 
Assignments are based on 1H, 13C, and DEPT-135 spectra. Liquid chromatography-mass 
spectrometry (LCMS) was performed on an Agilent HP 1100 series chromatograph (Mercury 
Luna 3µ C18 (2) column) attached to a Waters ZQ2000 mass spectrometer with ESCi 
ionisation source in ESI mode. Elution was carried out at a flow rate of 0.6 mL/min using a 
reverse phase gradient of MeOH–water or MeCN-water, both containing 0.1% formic acid. 
High resolution mass spectra (HRMS) were recorded on a Waters Micromass LCT Premier 
spectrometer using time of flight with positive electrospray ionisation (ESI+), an ABI/MDS 
Sciex Q-STAR Pulsar with ESI+ and an ASAP (atmospheric pressure solids analysis probe 
ionisation), or a Bruker BioApex II 4.7e FTICR utilising either ESI+ or a positive electron 
ionisation (EI+) source equipped with a direct insertion probe. The mass reported is that 
containing the most abundant isotopes (35Cl and 79Br).  
IR spectra were recorded neat on a Perkin-Elmer Spectrum Two FT-IR spectrometer using 
Universal ATR sampling accessories. Letters in parentheses refer to the relative absorbency 
of the peak: w – weak (30% of the most intense peak), m- medium (30-75% of the most 
intense peak), s- strong (%absorbance greater than 75%).  
Melting points were obtained using an Optimelt automated melting point system at a 
heating rate of 1 oC/min. All melting points are uncorrected. 
X-ray diffraction experiment was carried out on a D8 Venture 3-circle Bruker AXS 
diffractometer with a PHOTON 100 CMOS area detector, using graphite-monochromated 
Mo K radiation (  = 0.71073 Å) from IS microsource and a Cryostream (Oxford 
Cryosystems) open-flow N2 cryostat. The structure was solved by direct methods (SHELXS 
2013/1 software2 ) and refined by full-matrix least squares against F2 of all reflections, using 
OLEX23 and SHELXL 2014/7 software. 
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Elemental analysis of 4-phenyl-pyridine, 1a, was performed by ion chromatography and 
inductively coupled plasma optical emission spectroscopy. (ICP/OES)  
UV-visible spectra were recorded on a Cary-100 spectrophotometer thermostated to 25 oC. 
 
b) Procedure for Measurement of Acid Dissociation Constants: 
A series of acetic acid- potassium acetate and formic acid – potassium formate buffers with 
0.1 M ionic strength were prepared by adding the required amount of 0.5 M HCl solution to 
981 mg (10 mmol) of potassium acetate or 840 mg (10 mmol) potassium formate in a 100 ml 
volumetric flask. The volumes of HCl added are given below in Table 16. The pH of the buffer 
solutions thus prepared was measured using a pH probe calibrated in the range 1.79 – 4 or 4 
- 7. The measured pH’s of the buffer solutions are shown in Table 16 and 17.  
Acetic acid – potassium acetate buffers: 
Volume of 0.5 M HCl (mL) Calculated pH Measured pH 
18 3.80 3.46 
17 4.00 3.89 
15 4.28 4.14 
10 4.76 4.63 
7 5.03 4.91 
5 5.23 5.29 
2 5.71 5.68 
Table 16: pH values of acetate buffers prepared for pKa  measurement 
Formic acid – potassium formate buffers: 
Volume of 0.5 M HCl (mL) Calculated pH Measured pH 
18 2.80 2.69 
17 3.00 2.98 
15 3.27 3.22 
Table 17: pH values of formate buffers prepared for pKa  measurement 
The procedure following preparation and calibration of the buffer solutions is described 
below using the determination of the pKa of the conjugate acid of pyridine in a 1:1 
acetonitrile:water solution as an illustrative example: 
A 200 μM solution of pyridine was prepared in the chosen solvent system. 0.5 ml of this 
pyridine solution was then pipetted into a 1ml quartz cuvette along with 0.5 ml of a 0.1 M HCl 
solution. The cuvette was then placed into the cell of the spectrophotometer, the 
temperature of which was maintained at 25oC, and the absorbance of the solution was 
mapped in the 200-800 nanometer interval to obtain  λmax (Table 7). This process was then 
repeated using 0.5 ml of the pyridine solution and 0.5 ml of a 0.1 M KOH solution to obtain 
λmin (Table 7). The difference between the absorbance of pyridine (absorbance mapped in 
KOH solution) and that of its conjugate acid (absorbance mapped in HCl solution) appeared 
to be maximum at a wavelength of 254 nm (Table 7). The analytical wavelength, λobs, was 
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therefore chosen as 254 nm. Since the absorbance of the 200 μM pyridine solution in HCl 
solution lay between 0.8 and 1.2 Absorbance Units, 200 μM was chosen as the analyte 
concentration (Table 7).  
Having defined the above parameters Aobs was measured at 254 nm at different pH levels in 
the following manner. 
The absorbance of a 200 μM pyridine solution was measured at the analytical wavelength at 
different pH values by pipetting 0.5 ml of the analyte into the quartz cuvette along with 0.5 
ml of the relevant buffer solution (concentration of all buffer solutions used was 0.1 M). The 
data shown in Table 18 was thus generated. A plot of Aobs versus pH was graphed using 
Kaleidagraph v4.5 (Figure 34). Curve fitting of this plot using Equation 2 furnished the pKa for 
pyridine in a 1:1 MeCN:water solvent system, based on buffers calibrated in water.  
In Figure 34: m1 = Amax, -log(m2) = pKa, and m3 = Amin.  
pH Aobs 
1 1.012 
2.69 0.942 
2.98 0.899 
3.22 0.843 
3.46 0.609 
4.14 0.590 
4.63 0.476 
13 0.436 
Table 18:  pH vs. Aobs values for pyridine in 1:1::MeCN:water mixture 
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Figure 34: curve fit to Aobs v pH plot for pyridine  
 
 
c) Synthetic Procedures: 
Representative procedure for synthesis of 4-aryl pyridines 1a-r: To a 20ml microwave vial 
equipped with a magnetic stir bar were added 8 ml 1,2-dimethoxyethane, 2 ml deionized 
water, 650 mg (2 mmol) caesium carbonate, 0.2 ml of a 1M TBAF solution in THF, 58 mg (0.05 
mmol) tetrakis(triphenylphosphine)palladium(0), and 1.2 or 1.5 or 1.8 equivalents of the 
relevant boronic acid/pinacol ester. Finally, 195 mg (1.0 mmol) 4-bromopyridine 
hydrochloride were added to the vial following which it was capped and the temperature of 
the reaction mixture raised to 100 oC in a microwave reactor. After 60 minutes, the reaction 
mixture was allowed to cool to room temperature, filtered under vacuum through a silica gel 
plug, concentrated in-vacuo, and purified by flash chromatography eluting with an ethyl 
acetate-hexane mixture to yield the corresponding 4-aryl pyridine. 
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4-nitro-3-picoline-N-oxide, 2: To a 1000 ml flask equipped with a magnetic stir bar were added 
21.82 g (200 mmol) of 3-picoline-N-oxide, 76.5 g (900 mmol) sodium nitrate and 96 ml (1,802 
mmol) of concentrated sulfuric acid. The flask was then fitted with a reflux condenser and the 
reaction mixture kept stirring at 100 oC for 24 hours. The mixture was then allowed to cool to 
room temperature after which 50 ml deionized water and 200 ml dichloromethane were 
added and neutralization carried out with a K2CO3 solution, taking care not to let the pH of 
the aqueous layer increase above approximately 8. The organic layer was then separated and 
further extractions from the aqueous layer carried out with dichloromethane. The combined 
dichloromethane extracts were dried over sodium sulfate, concentrated in-vacuo, and 
purified by recrystallization from methanol to give 2 in 69% yield.  
 
3,5-lutidine-N-oxide, 8: 34.28 ml (600 mmol) glacial acetic acid and 48.96 ml (600 mmol) of a 
50% w/w aqueous hydrogen peroxide solution were taken in a flask and stirred for 10 
minutes. 68.37 ml (600 mmol) of 3,5-lutidine was then added to the flask, and the reaction 
mixture was kept stirring for 30 hours at 85 oC. The reaction mixture was then cooled 
gradually to 0oC, the residual peroxide reduced using sodium thiosulfate and sodium iodide 
as indicator, and neutralization carried out with K2CO3 solution. 3,5-lutidine-N-oxide was then 
extracted from the aqueous solution using a 15% solution of isopropanol in dichoromethane 
after which it was purified by recrystallization from ethyl acetate to give the product as white 
needle shaped crystals with 56% yield. 
 
4-nitro-3,5-lutidine-N-oxide,9: To a 1000 ml flask equipped with a magnetic stir bar were 
added 21.82g (200 mmol) of 3,5-lutidine-N-oxide, 76.5 g (900 mmol) sodium nitrate and 96 
ml (1,802 mmol) of concentrated sulfuric acid. The flask was then fitted with a reflux 
condenser and the reaction mixture kept stirring at 115 oC for 30 hours. The mixture was then 
allowed to cool to room temperature after which 50 ml deionized water and 200 ml 
dichloromethane were added and neutralization carried out with a K2CO3 solution, taking care 
not to let the pH of the aqueous layer increase above approximately 8. The organic layer was 
then separated and further extractions from the aqueous layer carried out with 
dichloromethane. The combined dichloromethane extracts were dried over sodium sulfate, 
concentrated in-vacuo, and purified by recrystallization from methanol to give 9 in 63% yield.   
 
Procedure for bromination of 2 or 9: To a 500 ml oven dried flask equipped with a magnetic 
stir bar were added 100 mmol of 2 or 9 and 91.4 ml (1600 mmol) of glacial acetic acid. The 
mixture was stirred till homogenous followed by dropwise addition of 33.28 ml (450 mmol) 
of acetyl bromide. After addition of acetyl bromide, the flask was fitted with a reflux 
condenser and stirred for 24 hours at 85 oC. The reaction mixture was then allowed to cool to 
room temperature, slowly poured onto crushed ice and neutralised using a K2CO3 solution, 
taking care not to let the pH of the resulting solution exceed 8. The neutralised solution was 
then extracted thrice with a 10% solution of isopropanol in dichloromethane, the organic 
layer dried over sodium sulfate and then concentrated in vacuo to furnish a brown powder. 
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This crude product was purified by flash chromatography eluting with 4% methanol in 
dichloromethane to furnish 4-bromo-3-picoline-N-oxide, 3 in 66% yield and 4-bromo-3,5-
lutidine-N-oxide, 10 in 58% yield. 
 
Procedure for reduction of 3 or 10: To an oven dried flask under a nitrogen atmosphere was 
added 50 ml dry THF. The flask was then cooled to -78 oC using a dry ice-acetone bath. To the 
chilled THF was added 5.49 ml (50 mmol) of TiCl4 and the resulting yellow suspension was 
allowed to stir for ten minutes. To this suspension were slowly added 1.9 g of LiAlH4 to furnish 
a black suspension. The reaction mixture was allowed to warm up to room temperature and 
then stirred for 1 hour after which it was again cooled to -78 oC. 50 mmol of 3 or 10 were then 
added to the flask and the resulting reaction mixture was then allowed to gradually warm up 
to room temperature and then left stirring for 90 minutes. After this period of time, the 
reaction mixture was quenched with a cold 5M solution of NH4OH and extracted 4 times with 
dichloromethane. The organic extract was dried over sodium sulfate, rapidly concentrated in 
vacuo, and the crude oil thus obtained purified by flash chromatography eluting with 20% 
ethyl acetate in hexane to furnish a solution of 4-bromo-3-picoline, 4, or 4-bromo-3,5-
lutidine, 11a. An excess of ethereal solution of HCl was then added to the solution of 4 or 11a 
in ethyl acetate-hexane to obtain 4-bromo-3-picoline hydrochloride, 5, or 4-bromo-3,5-
lutidine-hydrochloride, 11b in 60-66% yield.   
 
4-amino-3-picoline, 6:  10mmol of 2 were reduced using the same procedure as that used for 
the reduction of 3 or 10, but with three equivalents each of TiCl4 and LiAlH4. The crude product 
obtained after extraction and concentration in vacuo was purified by flash chromatography 
eluting with methanol to obtain 6 in 5-% yield. 
 
Representative procedure for synthesis of 4-aryl-3-picolines 7a-r: To a 20ml microwave vial 
equipped with a magnetic stir bar were added 8 ml 1,2-dimethoxyethane, 2 ml deionized 
water, 0.2 ml of a 1M TBAF solution in THF and 5 mg (0.022 mmol) palladium(II) acetate. 20 
mg (0.048 mmol) SPhos was dissolved in 0.5 ml toluene and then added to the vial after which 
the mixture was stirred till the solution turned dark red in colour. Then 650 mg (2 mmol) 
caesium carbonate was added followed by 1.2 or 1.5 or 1.8 mmol of the relevant boronic 
acid/pinacol ester and finally, 207 mg (1.0 mmol) of 4-bromo-3-picoline hydrochloride. The 
vial was then capped and the temperature of the reaction mixture raised to 100oC in a 
microwave reactor. After 40 minutes, the reaction mixture was allowed to cool to room 
temperature, filtered under vaccum through a silica gel plug, concentrated in-vacuo, and 
purified by flash chromatography eluting with an ethyl acetate-hexane mixture to yield the 
corresponding 4-aryl-3- picoline. 
 
Representative procedure for synthesis of 4-aryl-3,5-lutidines 12a-r: To a 20ml microwave vial 
equipped with a magnetic stir bar were added 8 ml 1,2-dimethoxyethane, 2 ml deionized 
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water, 0.2 ml of a 1M TBAF solution in THF and 5 mg (0.022 mmol) palladium(II) acetate. 20 
mg (0.048 mmol) SPhos was then dissolved in 0.5 ml toluene and then added to the vial after 
which the mixture was stirred till the solution turned dark red in color. Then 650 mg (2 mmol) 
caesium carbonate was added followed by 1.2 or 1.5 or 1.8 mmol of the relevant boronic 
acid/pinacol ester and finally, 221 mg (1.0 mmol) of 4-bromo-3,5-lutidine hydrochloride. The 
vial was then capped and the temperature of the reaction mixture raised to 125 oC in a 
microwave reactor. After 40 minutes, the reaction mixture was allowed to cool to room 
temperature, filtered under vaccum through a silica gel plug, concentrated in-vacuo, and 
purified by flash chromatography eluting with an ethyl acetate-hexane mixture to yield the 
corresponding 4-aryl-3,5-lutidine.  
 
Aldol condensation between propanal and 2-trifluoromethylbenzaldehyde/2-
nitrobenzaldehyde:  
Procedure A: To 5 ml of absolute ethanol were added 672 mg (12 mmol) of finely powdered 
KOH and the mixture was stirred till homogenous. 12 mmol of the relevant aldehyde and 
0.72 ml (10 mmol) of propanal  were dissolved in 5 ml of absolute ethanol and added 
dropwise through an addition funnel to the ethanolic KOH solution over 30 minutes at 
ambient temperature. The reaction was monitored by TLC, and after two hours was 
quenched with acetic acid and extracted using dichloromethane. The organic layer was 
dried over sodium sulfate and concentrated in vacuo to furnish a viscous orange gel. The 
same procedure was repeated at 0 and -10 oC . 
Procedure B: To an oven dried flask under an atmosphere of nitrogen was added 10 ml of 
dry THF and the flask was chilled to -78 oC. 1.4 ml (10 mmol) of diisopropylamine was then 
added to the flask followed by 4 ml of a 2.5 M solution of n-butyllithium in hexane. The 
mixture was stirred for 10 minutes at -78 oC followed by addition of 0.72 ml of propanal. 
After stirring for another hour at -78 oC, the mixture thus obtained was added in portions 
through a syringe to a second flask containing 12 mmol of the relevant aldehyde dissolved in 
10 ml of THF, kept at 0 oC. After addition of the propanal – diisopropylamine – butyllithium 
mixture, the reaction was monitored by TLC and quenched after 2 hours with acetic acid and 
extracted with dichloromethane. The organic layer was dried over sodium sulfate and 
concentrated in vacuo to furnish a yellow oil. 
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Spectroscopic Data 
 
4-phenylpyridine, 1a: 
 
Isolated yield: 95% 
1H NMR (400 MHz, Chloroform-d) δ 8.69 – 8.62 (m, 2H), 7.66 – 7.60 (m, 2H), 7.53 – 7.40 (m, 5H). 
13C NMR (101 MHz, Chloroform-d) δ 150.21 (2CH), 148.35 (C), 138.11 (C), 129.12 (2CH), 129.07 
(CH), 126.99(2CH), 121.64 (2CH). 
IR (neat) ν = 3037.4 (w), 1584.9 (m), 1544.6 (m), 1480.5 (m), 1410.4 (m), 1232.9 (m), 1190.2 (m), 
829.2 (m), 758.3 (s), 687.0 (m), 667.7 (m)  
Elemental Analysis: Calculated for C11H9N- C, 85.13%; H, 5.84%, N, 9.03%; found- C, 84.63% (Δ= -
0.5%); H, 5.83% (Δ= -0.01%); N, 8.98% (Δ= -0.03%) 
Melting point: 74.6 – 76.8 oC (1:9::AcOEt:Hexanes) 
 
4-(2-methylphenyl)pyridine, 1b: 
 
Isolated yield: 75% 
1H NMR (400 MHz, Chloroform-d) δ 8.72 – 8.59 (m, 2H), 7.38 – 7.17 (m, 6H), 2.30 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 149.77 (C) , 149.65 (2CH) , 139.09 (C) , 135.00 (C) , 130.67 
(CH), 129.26 (CH) , 128.39 (CH) , 126.12 (CH) , 124.26 (2CH) , 20.28 (CH3) . 
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LCMS(in MeCN): Rt=1.38min, m/z=170.3[M+H]+; HR-MS: calculated for C12H12N- 170.0970, found- 
170.0968 (Δ= -1.2ppm) 
 
IR (neat) ν = 3022.3 (w), 1594.0 (m), 1541.4 (m), 1479.5 (m), 1408.5 (m), 1217.0 (w), 828.4 (m), 759.4 
(s), 745.5 (m), 725.1 (m), 617.1 (m), 575.1 (m)  
 
4-(3-methylphenyl)pyridine, 1c: 
 
Isolated yield: 95% 
1H NMR (400 MHz, Chloroform-d) δ 8.69 – 8.63 (m, 2H), 7.52 – 7.48 (m, 2H), 7.46 – 7.42 (m, 2H), 
7.38 (t, J = 7.4, 1H), 7.26 (d, J = 7.4 Hz, 1H), 2.44 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 150.19 (2CH) , 148.19 (C) , 139.19 (C) , 135.14 (C) , 129.85 
(2CH) , 126.81 (2CH) , 121.38 (2CH) , 21.24 (CH3) . 
 
LCMS(in MeCN): Rt=1.49min, m/z=170.3[M+H]+; HR-MS: calculated for C12H12N- 170.0970, found- 
170.0974 (Δ= 2.4 ppm) 
 
IR (neat) ν = 3025.8 (w), 1592.8 (m), 1547.3 (m), 1480.7 (m), 1404.2 (m), 1408.5 (m), 1220.5 (w), 
827.0 (m), 778.6 (s), 717.5 (m), 696.9 (m), 615.7 (m), 582.8 (m)  
 
4-(4-methylphenyl)pyridine, 1d: 
 
Isolated yield: 95% 
1H NMR (400 MHz, Chloroform-d) δ 8.67 – 8.62 (m, 2H), 7.54 (d, J = 8.4 Hz, 2H), 7.51 - 7.47 (m, 
2H), 7.29 (d, J = 8.4 Hz, 2H), 2.42 (s, 3H). 
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13C NMR (101 MHz, Chloroform-d) δ 150.19 (2CH) , 148.19 (C) , 139.19 (C) , 135.14 (C) , 129.85 
(2CH) , 126.81 (2CH) , 121.38 (2CH) , 21.24 (CH3) . 
 
LCMS(in MeCN): Rt=1.44min, m/z=170.3[M+H]+; HR-MS: calculated for C12H12N- 170.0970, found- 
170.0966 (Δ= -2.4 ppm) 
 
IR (neat) ν = 3035.4 (w), 1596.0 (m), 1487.0 (m), 1234.4 (m), 1212.3 (m), 1028.4 (m), 990.8 (m), 798.8 
(s), 708.0 (m), 556.1 (m)  
Melting point: 97.0 – 97.8 oC (1:9::AcOEt:Hexanes) 
4-(2,4-dimethylphenyl)pyridine, 1e: 
 
Isolated yield: 82.5% 
1H NMR (400 MHz, Chloroform-d) δ 8.63 – 8.54 (m, 2H), 7.49 – 7.41 (m, 2H), 7.29 (d, J = 8.3 Hz, 
1H), 6.61 – 6.55 (m, 2H), 3.85 (s, 3H), 3.81 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 161.48 (C), 157.77 (C), 149.45 (2CH), 146.09 (C), 131.12 (CH), 
124.05 (2CH), 120.38 (C), 105.06 (CH), 99.06 (CH), 55.53 (CH3), 55.47 (CH3). 
 
LCMS(in MeOH): Rt = 2.27 min, m/z = 184.0[M+H]+; HR-MS: calculated for C13H14N- 184.1126, 
found- 184.1130 (Δ= 2.2 ppm) 
 
IR (neat) ν = 2940.4 (w), 2837.6 (w), 1610.3 (m), 1593.9 (m), 1207.3 (s), 1158.0 (s), 1070.1 (s), 990.9 
(m), 821.6 (m), 721.7 (m), 560.4 (s)  
4-(2-methoxyphenyl)pyridine, 1f: 
 
Isolated yield: 91% 
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1H NMR (400 MHz, Chloroform-d) δ 8.63 – 8.59 (m, 2H), 7.47 – 7.43 (m, 2H), 7.38 – 7.35 (m, 1H), 
7.34 – 7.29 (td, J = 7.5, 1.1 Hz, 1H), 7.03 (td, J = 7.5, 1.1 Hz, 1H), 6.97 (dd, J = 8.3, 1.0 Hz, 1H), 3.78 
(s, 3H). 
  
13C NMR (101 MHz, Chloroform-d) δ 156.52 (C) , 149.49 (2CH) , 146.27 (C) , 130.44 (CH) , 130.14 
(CH) , 127.59 (C) , 124.29 (2CH) , 121.06 (CH) , 111.42 (CH) , 55.48 (CH3) . 
 
LCMS(in MeCN): Rt=1.33min, m/z=186.3[M+H]+; HR-MS: calculated for C12H12NO- 186.0919, 
found- 186.0921 (Δ=1.1ppm) 
 
IR (neat) ν = 3016.9 (w), 2966.4 (w), 1606.7 (m), 1590.5 (m), 1483.2 (m), 1457.1 (m), 1409.7 (m), 
1215.4 (m), 801.7 (m), 759.5 (s), 609.8 (m), 580.5 (m), 552.5 (m)  
Melting point: 76.6 – 79.5 oC (1:9::AcOEt:Hexanes) 
 
4-(3-methoxyphenyl)pyridine, 1g: 
 
Isolated yield: 78% 
1H NMR (400 MHz, Chloroform-d) δ 8.71 – 8.63 (m, 2H), 7.52 – 7.48 (m, 2H), 7.41 (t, J = 7.9 Hz, 
1H), 7.22 (ddd, J = 7.7, 1.7, 0.9 Hz, 1H), 7.16 (dd, J = 2.5, 1.7 Hz, 1H), 6.99 (ddd, J = 8.3, 2.6, 1.0 Hz, 
1H), 3.88 (s, 3H). 
  
13C NMR (101 MHz, Chloroform-d) δ 160.15 (C) , 150.19 (2CH) , 148.23 (C) , 139.59 (C) , 130.17 
(CH) , 121.69 (2CH) , 119.39 (CH) , 114.32 (CH) , 112.79 (CH) , 55.36 (CH3) . 
 
LCMS(in MeCN): Rt=1.69min, m/z=186.1[M+H]+; HR-MS: calculated for C12H12NO- 186.0919, 
found- 186.0928 (Δ= 4.8ppm) 
 
IR (neat) ν = 2938.5 (w), 2835.0 (w), 1592.5 (m), 1548.0 (m), 1477.8 (m), 1406.9 (m), 1215.4 (s), 
1172.8 (m), 1030.9 (m), 822.0 (m), 776.1 (s), 713.7 (m), 652.7 (m), 611.7 (m)  
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4-(4-methoxyphenyl)pyridine, 1h: 
 
Isolated yield: 80% 
Melting point: 97.0 – 97.8oC 
1H NMR (400 MHz, Chloroform-d) δ 8.62 – 8.56 (m, 2H), 7.61 – 7.55 (m, 2H), 7.48 – 7.41 (m, 2H), 
7.02 – 6.96 (m, 2H), 3.84 (s, 3H).  
 
13C NMR (101 MHz, Chloroform-d) δ 160.53 (C), 150.15 (2CH), 147.79 (C), 130.30 (C), 128.13 (2CH), 
121.03 (2CH), 114.54 (2CH), 55.38 (CH3). 
 
LCMS(in MeOH): Rt = 1.52 min, m/z = 186.1[M+H]+; HR-MS: calculated for C12H12NO- 186.0919, 
found- 186.0921 (Δ= 1.1 ppm) 
 
IR (neat) ν = 3022.0 (w), 1604.4 (m), 1592.6 (m), 1578.3 (m), 1462.2 (m), 1409.7 (m), 1284.6 (m), 
1253.9 (m), 1223.7 (m), 1182.3 (m), 1033.8 (m), 1014.9 (m), 806.0 (s), 567.9 (m), 498.7 (m) 
 
4-(2,4-dimethoxyphenyl)pyridine, 1i: 
 
Isolated yield: 80% 
Melting point: 69.0 – 70.8oC 
1H NMR (400 MHz, Chloroform-d) δ 8.62 – 8.56 (m, 2H), 7.61 – 7.55 (m, 2H), 7.48 – 7.41 (m, 2H), 
7.02 – 6.96 (m, 2H), 3.84 (s, 3H).  
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13C NMR (101 MHz, Chloroform-d) δ 161.48 (C), 157.77 (C), 149.44 (2CH), 146.11 (C), 131.13 (CH), 
124.07 (2CH), 120.43 (C), 105.05 (CH), 99.08 (CH), 55.56 (CH3), 55.49 (CH3). 
 
LCMS(in MeCN): Rt=1.42min, m/z=216.4[M+H]+; HR-MS: calculated for C13H14NO2- 216.1025, 
found- 216.1035 (Δ= 4.6 ppm) 
 
IR (neat) ν = 3016.9 (w), 2966.5 (w), 1606.7 (m), 1590.5 (m), 1483.2 (m), 1457.1 (m), 1409.7 (m), 
1215.4 (m), 1121.9 (m), 1024.19 (m), 1016.6 (m), 828.17 (m), 759.5 (s), 609.8 (m), 580.5 (m)  
 
4-(2-trifluoromethylphenyl)pyridine, 1j: 
 
Isolated yield: 74% 
1H NMR (400 MHz, Chloroform-d) δ 8.68 – 8.61 (m, 2H), 7.76 (d, J = 7.6 Hz, 1H), 7.59 (t, J = 7.6, 
1H), 7.52 (t, J = 7.6 Hz, 1H), 7.29 (d, J = 7.6 Hz, 1H), 7.27 – 7.24 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 149.28 (2CH), 147.74 (C), 138.36 (q, J = 2.1 Hz, C), 131.66 
(CH), 131.21 (CH), 128.38 (CH), 128.13 (q, J = 30.3 Hz, C), 125.20 (q, J = 274.7 Hz, CF3), 126.27 (q, 
J = 5.3 Hz, CH), 123.91 (q, J = 1.6 Hz, 2CH). 
 
19F NMR (376 MHz, Chloroform-d) δ -56.72 (3F) 
 
LCMS(in MeCN): Rt=2.85min, m/z=224.4[M+H]+; HR-MS: calculated for C12H9NF3- 224.0687, 
found- 224.0693 (Δ=2.7ppm) 
 
IR (neat) ν = 3037.2 (w), 1596.3 (m), 1482.5 (w), 1448.8 (m), 1408.9 (w), 1312.5 (s), 1264.2 (m), 
1171.3 (m), 1108.3 (s), 1075.1 (m), 1034.0 (m), 826.1 (m), 767.9 (s), 615.4 (m)  
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4-(3-trifluoromethylphenyl)pyridine, 1k: 
 
Isolated yield: 52%  
1H NMR (400 MHz, Chloroform-d) δ 8.29 – 8.20 (m, 2H), 7.71 (td, J = 7.5, 1.4 Hz, 2H), 7.65 – 7.60 
(m, 2H), 7.37 – 7.29 (m, 2H).  
 
13C NMR (101 MHz, Chloroform-d) δ 150.52 (2CH), 146.88 (C), 139.05 (C), 131.63 (q, J = 32.6 Hz 
C), 130.32 (q, J = 1.5 Hz, CH), 129.70 (CH), 125.70 (q, J = 3.8 Hz, CH), 123.91 (q, J = 273.71 Hz, 
CF3), 123.86 (q, J = 3.8 Hz, CH), 121.63 (2CH). 
 
19F NMR (376 MHz, Chloroform-d) δ -62.71 (3F) 
 
LCMS(in MeCN): Rt=2.06min, m/z=224.4[M+H]+; HR-MS: calculated for C12H9NF3- 224.0687, 
found- 224.0694 (Δ=3.1ppm) 
 
IR (neat) ν = 1592.7 (m), 1552.7 (w), 1483.4 (w), 1439.6 (w), 1407.0 (w), 1333.9 (s), 1264.6 (m), 
1164.4 (m), 1119.8 (s), 1097.0 (m), 1077.6 (m), 1042.7 (m), 794.4 (s), 698.06 (m), 636.6 (m), 613.0 
(m)  
 
4-(4-trifluoromethylphenyl)pyridine, 1l: 
 
Isolated yield: 75% 
1H NMR (400 MHz, Chloroform-d) δ 8.77 – 8.70 (m, 2H), 7.76 (s, 4H), 7.55 – 7.49 (m, 2H). 
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13C NMR (101 MHz, Chloroform-d) δ 150.45 (2CH), 146.77 (C), 141.65 (q, J = 1.4 Hz, C), 130.95 (q, 
J = 32.7 Hz, C), 127.36 (2CH), 126.01 (q, J = 3.8 Hz, 2CH), 126.01 (q, J = 272.7 Hz, CF3), 121.63 
(2CH). 
 
19F NMR (376 MHz, Chloroform-d) δ -62.70 (3F). 
 
LCMS(in MeCN): Rt=2.51min, m/z=224.4[M+H]+; HR-MS: calculated for C12H9NF3- 224.0687, 
found- 224.0696 (Δ=4.0ppm) 
 
IR (neat) ν = 1596.9 (m), 1548.3 (w), 1401.1 (m), 1322.3 (s), 1121.3 (m), 1110.6 (m), 1070.0 
(m), 1025.9 (m), 1015.3 (m), 811.0 (s), 730.0 (s), 645.5 (w), 604.1 (m) 
 
4-(2-nitrophenyl)pyridine, 1m: 
 
Isolated yield: 34% 
1H NMR (400 MHz, Chloroform-d) δ 8.71 – 8.61 (m, 2H), 7.97 (dd, J = 8.1, 1.3 Hz, 1H), 7.68 (td, J = 
7.6, 1.3 Hz, 1H), 7.57 (dd, J = 8.1, 7.5, 1.5 Hz, 1H), 7.41 (dd, J = 7.6, 1.5 Hz, 1H), 7.27 – 7.20 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 149.97 (2CH), 148.46 (C), 145.77 (C), 133.96 (C), 132.99 (CH), 
131.52 (CH), 129.51 (CH), 124.59 (CH), 122.76 (2CH). 
 
LCMS(in MeCN): Rt=1.27 min, m/z=201.8[M+H]+; HR-MS: calculated for C11H9N2O2- 201.0664, 
found- 201.0672 (Δ=4.0ppm) 
 
IR (neat) ν = 3023.9 (w), 1592.8 (m), 1520.3 (s), 1410.3 (m), 1350.8 (s), 1314.9 (m), 854.6 (s), 824.8 
(m), 783.7 (s), 704.9 (s), 666.9 (m), 524.7 (m) 
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4-(3-nitrophenyl)pyridine, 1n: 
 
Isolated yield: 66% 
1H NMR (400 MHz, Chloroform-d) δ 8.74 – 8.68 (m, 2H), 8.47 (t, J = 2.0 Hz, 1H), 8.27 (ddd, J = 8.2, 
2.3, 1.0 Hz, 1H), 7.96 (ddd, J = 7.7, 1.8, 1.0 Hz, 1H), 7.68 (t, J = 8.0 Hz, 1H), 7.56 – 7.51 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 150.67 (2CH), 148.81 (C), 145.76 (C), 139.84 (C), 132.90 (CH), 
130.25 (CH), 123.70 (CH), 121.92 (CH), 121.52 (2CH). 
 
LCMS(in MeCN): Rt=1.30 min, m/z=201.4[M+H]+; HR-MS: calculated for C11H9N2O2- 201.0664, 
found- 201.0671 (Δ=3.5ppm) 
 
IR (neat) ν = 3088.6 (w), 1596.0 (w), 1525.0 (m), 1475.7 (m), 1412.5 (m), 1346.9 (s), 880.6 (m), 803.1 
(s), 730.7 (s), 682.2 (s), 610.0 (m), 538.0 (m) 
Melting point: 111.2 – 111.9 oC (1:4::AcOEt:Hexanes) 
 
4-(4-nitrophenyl)pyridine, 1o: 
 
Isolated yield: 78% 
Melting point: 123.6 – 125.1oC  
1H NMR (400 MHz, Chloroform-d) δ 8.73 – 8.67 (m, 2H), 8.31 (d, J = 8.8 Hz, 2H), 7.78 (d, J = 8.8 Hz, 
2H), 7.56 – 7.51 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 150.44 (2CH), 148.16 (C), 146.10 (C), 144.35 (C), 128.03 (2CH), 
124.32 (2CH), 121.82 (2CH). 
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LCMS(in MeCN): Rt=1.37 min, m/z=201.9[M+H]+; HR-MS: calculated for C11H9N2O2- 201.0664, 
found- 201.0667 (Δ=1.5ppm) 
 
IR (neat) ν = 3016.2 (w), 1592.1 (m), 1513.2 (m), 1342.5 (s), 1220.9 (m), 1071.9 (m), 854.6 (m), 812.7 
(m), 752.4 (m), 732.3 (m), 693.2 (m), 553.4 (m) 
Melting point: 123.6 – 125.1 oC (1:4::AcOEt:Hexanes) 
 
4-(2-cyanophenyl)pyridine, 1p: 
 
Isolated yield: 81% 
1H NMR (400 MHz, Chloroform-d) δ 8.77 – 8.70 (m, 2H), 7.81 (dd, J = 8.1, 1.4 Hz, 1H), 7.71 (td, J = 
8.0, 1.2 Hz, 1H), 7.57 – 7.52 (m, 2H), 7.51 – 7.47 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 150.24 (2CH), 145.58 (C), 142.39 (C), 134.05 (CH), 133.25 
(CH), 129.81 (CH), 129.00 (CH), 123.32 (2CH), 117.94 (C), 111.09 (C). 
 
LCMS(in MeCN): Rt=1.26 min, m/z=181.3[M+H]+; HR-MS: calculated for C12H9N2- 181.0766, found- 
181.0770 (Δ=2.2ppm) 
 
IR (neat) ν = 3247.8 (w), 2225.6 (m, CN), 1602.7 (m), 1595.8 (m), 1545.2 (m), 1479.7 (m), 1412.7 (m), 
997.3 (m), 832.2 (m), 766.7 (s) 
 
4-(3-cyanophenyl)pyridine, 1q: 
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Isolated yield: 81% 
1H NMR (400 MHz, Chloroform-d) δ 8.65 – 8.58 (m, 2H), 7.81 (s, 1H), 7.78 (d, J = 7.8, 1H), 7.62 (d, 
J = 7.8, 1H), 7.52 (t, J = 7.8 Hz, 1H), 7.41 – 7.38 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 150.55 (2CH), 145.81 (C), 139.28 (C), 132.32 (CH), 131.28 
(CH), 130.51 (CH), 130.04 (CH), 121.40 (2CH), 118.30 (C), 113.30 (C). 
 
LCMS(in MeOH): Rt = 1.31 min, m/z = 181.1[M+H]+; HR-MS: calculated for C12H9N2- 181.0766, 
found- 181.0770 (Δ= 2.2 ppm) 
 
IR (neat) ν = 3045.6 (w), 2226.7 (m, CN), 1595.2 (m), 1477.9 (m), 1396.3 (m), 787.3 (s), 821.8 (m), 
689.5 (s), 615.1 (s), 526.4 (m) 
Melting point: 111.0 – 113.3 oC (3:7::AcOEt:Hexanes) 
 
4-(4-cyanophenyl)pyridine, 1p: 
 
Isolated yield: 69% 
1H NMR (400 MHz, Chloroform-d) δ 8.75 – 8.70 (m, 2H), 7.81 – 7.71 (m, 4H), 7.53 – 7.48 (m, 2H). 
  
13C NMR (101 MHz, Chloroform-d) δ 150.62 (2CH), 146.30 (C), 142.59 (C), 132.90 (2CH), 127.77 
(2CH), 121.60 (2CH), 118.40 (C), 112.78 (C). 
 
LCMS(in MeCN): Rt=1.16 min, m/z=181.3[M+H]+; HR-MS: calculated for C12H9N2- 181.0766, found- 
181.0770 (Δ=2.2ppm) 
 
IR (neat) ν = 3034.2 (w), 2228.2 (m, CN), 1597.5 (m), 1399.5 (m), 850.1 (m), 801.7 (s), 689.8 (m), 
527.0 (s), 515.7 (m) 
Melting point: 79.4 – 81.1 oC (3:7::AcOEt:Hexanes) 
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4-(2-hydroxymethylphenyl)-pyridine: 
 
Isolated yield: 76% 
1H NMR (400 MHz, Chloroform-d) δ 8.63 – 8.54 (m, 2H), 7.63 (dd, J = 7.5, 1.5 Hz, 1H), 7.47 (td, J = 
7.5, 1.6 Hz, 1H), 7.41 (td, J = 7.5, 1.5 Hz, 1H), 7.38 – 7.34 (m, 2H), 7.31 – 7.26 (m, 1H), 4.61 (s, 2H). 
13C NMR (101 MHz, Chloroform-d) δ 149.41(2CH), 148.87(C), 138.54(C), 138.00(C), 129.52(CH), 
129.09(CH), 128.88(CH), 127.97(CH), 124.34(2CH), 62.54(CH2). 
LCMS(in MeCN): Rt= 0.97 min, m/z=186.0[M+H]+; HR-MS: calculated for C12H12NO- 186.0919, 
found- 184.00924 (Δ= 2.7 ppm) 
 
IR (neat) ν = 3142.3 (m, OH), 2871.0 (w), 2821.0 (w), 1598.9 (m), 1409.8 (m), 1321.3 (m), 1047.1 (m), 
998.6 (m), 840.9 (s), 761.0 (s), 748.7 (s), 619.9 (m) 
 
4-(4-hydroxymethylphenyl)-pyridine: 
 
Isolated yield: 74% 
1H NMR (400 MHz, Chloroform-d) δ 8.63 – 8.54 (m, 2H), 7.63 (dd, J = 7.5, 1.5 Hz, 1H), 7.47 (td, J = 
7.5, 1.6 Hz, 1H), 7.41 (td, J = 7.5, 1.5 Hz, 1H), 7.38 – 7.34 (m, 2H), 7.31 – 7.26 (m, 1H), 4.61 (s, 2H). 
13C NMR (101 MHz, Chloroform-d) δ 150.17 (2CH), 148.09 (C), 142.21 (C), 137.24 (C), 127.58 (2CH), 
127.13 (2CH), 121.58 (2CH), 64.68 (CH2). 
 
LCMS(in MeCN): Rt=1.11 min, m/z=186.0[M+H]+; HR-MS: calculated for C12H12NO- 186.0919, 
found- 186.0924 (Δ= 2.7 ppm) 
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IR (neat) ν = 3154.1 (m, OH), 2819.5 (w), 1598.1 (m), 1400.1 (m), 1056.6 (m), 1000.3 (m), 802.8 (s), 
720.1 (m) 
 
4-(2-formylphenyl)pyridine, 1p: 
 
Isolated yield: 62% 
1H NMR (400 MHz, Chloroform-d) δ 9.97 (s, 1H), 8.84 – 8.57 (m, 2H), 8.05 (dd, J = 7.8, 1.4 Hz, 1H), 
7.69 (td, J = 7.5, 1.5 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.42 (dd, J = 7.7, 1.3 Hz, 1H), 7.37 – 7.21 (m, 
2H).  
 
13C NMR (101 MHz, Chloroform-d) δ 191.13 (CHO), 149.76 (2CH), 145.90 (C), 142.68 (C), 133.90 
(CH), 133.43 (C), 130.36 (CH), 129.04 (CH), 128.38 (CH), 124.75 (2CH). 
 
LCMS(in MeCN): Rt=1.16 min, m/z=181.3[M+H]+; HR-MS: calculated for C12H10NO- 184.0762, 
found- 184.0762 (Δ= 0.0 ppm) 
 
IR (neat) ν = 3043.8 (w), 1692.9 (m, CHO), 1594.5 (m), 1405.2 (m), 1256.8 (m), 1196.5 (m), 836.7 (s), 
771.9 (s), 761.8 (s), 642.3 (m), 614.3 (m) 
 
4-(4-formylphenyl)pyridine, 1p: 
 
Isolated yield: 75% 
1H NMR (400 MHz, Chloroform-d) δ 10.08 (s, 1H), 8.79 – 8.61 (m, 2H), 8.00 (d, J = 8.1 Hz, 2H), 7.80 
(d, J = 8.2 Hz, 2H), 7.60 – 7.50 (m, 2H). 
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13C NMR (101 MHz, Chloroform-d) δ 191.61 (C=O), 150.52 (2CH), 146.90 (CH), 143.96 (CH), 136.47 
(CH), 130.42 (2CH), 127.73 (2CH), 121.75 (2CH). 
 
LCMS(in MeCN): Rt=1.01 min, m/z=184.0[M+H]+; HR-MS: calculated for C12H10NO- 184.0762, 
found- 184.0768 (Δ= 3.3 ppm) 
 
IR (neat) ν = 3057.2 (w), 1694.5 (m, C=O), 1680.8 (m), 1594.7 (m), 1213.2 (m), 1167.9 (m), 843.7 (m), 
799.4 (s), 735.2 (s), 720.2 (m), 694.9 (m) 
 
4-(2-carbomethoxyphenyl)pyridine, 1p: 
 
Isolated yield: 47% 
1H NMR (400 MHz, Chloroform-d) δ 8.72 – 8.56 (m, 2H), 7.93 (dd, J = 1.5, 7.9 Hz, 1H), 7.59 (td, J = 
7.5, 1.5 Hz, 1H), 7.50 (td, J = 7.6, 1.3 Hz, 1H), 7.33 (dd, J = 1.3, 7.7 Hz, 1H), 7.26 – 7.20 (m, 2H), 3.67 
(s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 168.05 (C), 149.42 (2CH), 140.04 (C), 131.77 (CH), 130.37 
(CH), 130.33 (CH), 130.18 (C), 128.40 (CH), 123.35 (2CH), 52.06 (CH3). 
 
LCMS(in MeCN): Rt=1.59 min, m/z=214.0[M+H]+; HR-MS: calculated for C13H12NO2- 214.0868, 
found- 214.0874 (Δ= 2.8 ppm) 
 
IR (neat) ν = 2951.0 (w), 1721.3 (s, C=O), 1594.4 (m), 1409.2 (m), 1287.5 (s), 1256.8 (s), 1127.2 (m), 
1092.4 (m), 911.5 (m), 761.4 (s), 728.0 (s), 614.9 (m) 
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4-(4-carbomethoxyphenyl)pyridine, 1p: 
 
Isolated yield: 56% 
1H NMR (400 MHz, Chloroform-d) δ 8.80 – 8.54 (m, 2H), 8.12 (d, J = 8.4 Hz, 2H), 7.67 (d, J = 8.4 Hz, 
2H), 7.56 – 7.42 (m, 2H), 3.92 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 166.51 (C), 150.42 (2CH), 147.06 (C), 142.40 (C), 130.55 (C), 
130.32 (2CH), 126.99 (2CH), 121.65 (2CH), 52.27 (CH3). 
 
LCMS(in MeCN): Rt=1.76 min, m/z=214.0[M+H]+; HR-MS: calculated for C13H12NO2- 214.0868, 
found- 214.0874 (Δ= 2.8 ppm) 
 
IR (neat) ν = 1717.2 (s, C=O), 1595.6 (m), 1421.3 (m), 1278.0 (s), 1180.1 (m), 1101.1 (s), 816.4 (s), 
954.1 (m), 764.7 (s), 700.3 (m), 647.3 (m) 
Melting point: 103.2 – 104.2 oC (2:8::AcOEt:Hexanes) 
 
3-methyl-4-nitropyridine-N-oxide, 2: 
 
Isolated yield: 69% 
1H NMR (400 MHz, Chloroform-d) δ 8.14 – 8.12 (m, 1H), 8.12 – 8.08 (m, 1H), 8.01 (d, J = 7.1 Hz, 
1H), 2.62 (s, 3H). 
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4-bromo-3-methylpyridine-N-oxide, 3: 
 
 
 
Isolated yield: 66% 
 
1H NMR (400 MHz, Chloroform-d) δ 8.12 – 8.06 (m, 1H), 7.95 – 7.90 (m, 1H), 7.41 (d, J = 6.8 Hz, 
1H), 2.33 (s, 3H). 
 
 
 
 
 
4-bromo-3-methylpyridine, 4: 
 
 
 
Isolated yield: 63% 
 
1H NMR (400 MHz, Chloroform-d) δ 8.39 (s, 1H), 8.20 (d, J = 7 Hz, 1H), 7.44 (d, J = 5.2 Hz, 1H), 
2.35 (s, 3H). 
 
 
4-bromo-3-methylpyridine hydrochloride, 5: 
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Isolated yield: 66% 
 
1H NMR (400 MHz, Methanol-d4) δ 8.88 (s, 1H), 8.66 (d, J = 6.4 Hz, 1H), 8.31 (d, J = 6.0 Hz, 1H), 
2.60 (s, 3H). 
 
1H NMR (400 MHz, Chloroform-d) δ 15.40 (s, 1H), 8.83 (s, 1H), 8.63 (d, J = 6.1 Hz, 1H), 8.10 (d, J = 
6.1 Hz, 1H), 2.55 (s, 3H). 
 
 
4-amino-3-methylpyridine 6: 
 
 
 
Isolated yield: 50% 
1H NMR (400 MHz, Chloroform-d) δ 8.06 – 7.99 (m, 2H), 6.46 (d, J = 5.5 Hz, 1H), 4.47 (s, 2H), 2.04 
(s, 3H). 
 
4-phenyl-3-methylpyridine, 7a: 
 
Isolated yield: 83% 
1H NMR (400 MHz, Chloroform-d) δ 8.50 (s, 1H), 8.46 (d, J = 5.0 Hz, 1H), 7.48 – 7.37 (m, 3H), 7.34 
– 7.30 (m, 2H), 7.14 (d, J = 5.0 Hz, 1H), 2.27 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 151.31 (CH), 149.15 (C), 147.39 (CH), 139.09 (C), 130.59 (C), 
128.54 (2CH), 128.44 (2CH), 127.95 (CH), 123.99 (CH), 17.25 (CH). 
 
LCMS(in MeOH): Rt = 1.72 min, m/z = 170.3 [M+H]+; HR-MS: calculated for C12H12N - 170.0970, 
found- 170.0963 (Δ= -4.1 ppm) 
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IR (neat) ν = 3028.3 (w), 1590.3 (m), 1477.7 (m), 1403.9 (m), 835.4 (m), 769.7 (m), 741.9 (m), 700.4 
(s), 628.0 (m), 578.7 (m), 570.9 (m), 513.3 (m) 
 
4-(2-methylphenyl)-3-methylpyridine, 7b: 
 
Isolated yield: 57% 
1H NMR (400 MHz, Chloroform-d) δ 8.51 (s, 1H), 8.46 (d, J = 4.9 Hz, 1H), 7.33 – 7.21 (m, 3H), 7.07 
– 7.02 (m, 2H), 2.06 – 2.04 (m, 6H). 
 
13C NMR (101 MHz, Chloroform-d) δ 150.89 (CH), 149.46 (C), 147.16 (CH), 138.69 (C), 134.96 (C), 
131.43 (C), 130.16 (CH), 128.34 (CH), 128.02 (CH), 125.83 (CH), 123.98 (CH), 19.65 (CH3), 16.62 
(CH3). 
 
LCMS(in MeOH): Rt = 2.10 min, m/z = 184.0 [M+H]+; HR-MS: calculated for C13H14N - 184.1126, 
found- 184.1127 (Δ= 0.5 ppm) 
 
IR (neat) ν = 2900 (w), 1530 (m), 1460 (m), 1390 (m), 820 (m), 760 (s), 720 (s), 690 (s), 630 (m), 600 
(m) 
 
4-(3-methylphenyl)-3-methylpyridine, 7c: 
 
Isolated yield: 87% 
1H NMR (400 MHz, Chloroform-d) δ 8.49 (s, 1H), 8.45 (d, J = 5.0 Hz, 1H), 7.33 (t, J = 7.5 Hz, 1H), 
7.21 (d, J = 7.6 Hz, 1H), 7.15 – 7.09 (m, 3H), 2.41 (s, 3H), 2.27 (s, 3H). 
85 
 
 
13C NMR (101 MHz, Chloroform-d) δ 151.17 (CH), 149.39 (C), 147.24 (CH), 139.04 (C), 138.11 (C), 
130.64 (C), 129.20 (CH), 128.67 (CH), 128.30 (CH), 125.60 (CH), 124.01 (CH), 21.45 (CH3), 17.24 
(CH3). 
 
LCMS(in MeOH): Rt = 2.06 min, m/z = 184.0 [M+H]+; HR-MS: calculated for C13H14N - 184.1126, 
found- 184.1131 (Δ= 2.7 ppm) 
 
IR (neat) ν = 2922.8 (m), 1589.1 (m), 1548.1 (w), 1476.2 (m), 834.1 (m), 785.8 (s), 749.9 (m), 705.6 
(s), 632.3 (m), 597.8 (m), 576.5 (m) 
 
4-(4-methylphenyl)-3-methylpyridine, 7d: 
 
Isolated yield: 72% 
1H NMR (400 MHz, Chloroform-d) δ 8.51 (s, 1H), 8.47 (d, J = 5.0 Hz, 1H), 7.28 (d, J = 8.1 Hz, 2H), 
7.24 (d, J = 8.2 Hz, 2H), 7.15 (d, J = 5.0 Hz, 1H), 2.43 (s, 3H), 2.30 (s, 3H) 
13C NMR (101 MHz, Chloroform-d) δ 151.27 (CH), 149.17 (C), 147.34 (CH), 137.82 (C), 136.16 (C), 
130.64 (C), 129.14 (2CH), 128.48 (2CH), 124.05 (CH), 21.24 (CH3), 17.31 (CH3). 
LCMS(in MeOH): Rt = 2.06 min, m/z = 184.1 [M+H]+; HR-MS: calculated for C13H14N - 184.1126, 
found- 184.1126 (Δ= 0.0 ppm) 
 
IR (neat) ν = 2921.3 (w), 1591.3 (m), 1516.1 (m), 1481.9 (m), 812.8 (s), 752.4 (m), 697.1 (m), 577.4 
(m), 552.9 (m), 514.5 (m) 
 
 
 
 
 
 
 
4-(2,4-dimethylphenyl)-3-methylpyridine, 7e: 
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Isolated yield: 51% 
1H NMR (400 MHz, Chloroform-d) δ 8.49 (s, 1H), 8.43 (d, J = 4.9, 1H), 7.10 (app. s, 1H), 7.05 (d, J = 
7.8 Hz, 1H), 7.02 (d, J = 4.9 Hz, 1H), 6.93 (d, J = 7.7 Hz, 1H), 2.36 (s, 3H), 2.05 (s, 3H), 2.01 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 150.85(CH), 149.50(C), 147.13(CH), 137.65(C), 135.81(C), 
134.76(C), 131.59(C), 130.90(CH), 128.28(CH), 126.51(CH), 124.22(CH), 21.14(CH3), 19.56(CH3), 
16.65(CH3). 
 
LCMS(in MeOH): Rt = 2.13 min, m/z = 198.1 [M+H]+; HR-MS: calculated for C14H16N – 198.1276, 
found- 198.1285 (Δ= 1.0 ppm) 
 
IR (neat) ν = 2920.9 (w), 1615.4 (m), 1519.3 (m), 1480.6 (m), 1404,2 (m), 820.2 (s), 697.8 (m), 598.9 
(m), 569.0 (m), 527.3 (m) 
 
4-(2-methoxyphenyl)-3-methylpyridine, 7g: 
 
Isolated yield: 82% 
1H NMR (400 MHz, Chloroform-d) δ 8.54 – 8.38 (m, 2H), 7.38 (ddd, J = 8.3, 7.4, 1.9 Hz, 1H), 7.10 
(m, 2H), 7.03 (td, J = 7.4, 1.1 Hz, 1H), 6.98 (dd, J = 8.3, 1.0 Hz, 1H), 3.76 (s, 3H), 2.13 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 156.13 (C), 150.50 (CH), 146.96 (CH), 146.65 (C), 132.33 (C), 
130.24 (CH), 129.60 (CH), 128.02 (C), 124.64 (CH), 120.66 (CH), 110.83 (CH), 55.37 (CH3), 16.79 
(CH3). 
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LCMS(in MeOH): Rt = 1.83 min, m/z = 200.1[M+H]+; HR-MS: calculated for C13H14NO- 200.1075, 
found- 200.1076 (Δ= 0.5 ppm) 
 
IR (neat) ν = 2959.4 (w), 2836.0 (w), 1602.7 (m), 1480.0 (m), 1433.9 (m), 1268.7 (m), 1237.7 (m), 
1119.3 (m), 1053.4 (m), 1026.3 (m), 834.5 (m), 821.3 (m), 790.4 (m), 752.5 (s), 625.7 (m) 
 
4-(3-methoxyphenyl)-3-methylpyridine, 7h: 
 
Isolated yield: 67% 
1H NMR (400 MHz, Chloroform-d) δ 8.49 (s, 1H), 8.45 (d, J = 5.2 Hz, 1H), 7.35 (t, J = 8 Hz, 1H), 7.14 
(d, J = 5.0 Hz, 1H), 6.94 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 6.89 (ddd, J = 7.6, 1.6, 1.0 Hz, 1H), 6.84 (dd, 
J = 2.6, 1.5 Hz, 1H), 3.83 (s, 3H), 2.27 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 159.52 (C), 151.25 (CH), 149.09 (C), 147.30 (CH), 140.44 (C), 
130.62 (C), 129.51 (CH), 123.89 (CH), 120.93 (CH), 114.34 (CH), 113.29 (CH), 55.31 (CH3), 17.23 
(CH3). 
 
LCMS(in MeOH): Rt = 1.86 min, m/z = 200.1[M+H]+; HR-MS: calculated for C13H14NO- 200.1075, 
found- 200.1085 (Δ= 5.0 ppm) 
 
IR (neat) ν = 2957.7 (s), 1588.2 (s), 1477.2 (m), 1427.6 (m), 1292.3 (m), 1218.6 (s), 1167.3 (m), 1052.9 
(m), 1030.9 (m), 833.2 (m), 783.1 (m), 701.4 (s), 625.5 (m) 
4-(4-methoxyphenyl)-3-methylpyridine, 7i: 
 
Isolated yield: 56% 
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1H NMR (400 MHz, Chloroform-d) δ 8.46 (s, 1H), 8.42 (d, J = 5.0 Hz, 1H), 7.28 – 7.23 (m, 2H), 7.12 
(d, J = 5.0 Hz, 1H), 6.99 – 6.94 (m, 2H), 3.84 (s, 3H), 2.27 (s, 3H). 
13C NMR (101 MHz, Chloroform-d) δ 159.41 (C), 151.26 (CH), 148.82 (C), 147.31 (CH), 131.34 (C), 
130.65 (C), 129.83 (2CH), 124.05 (CH), 113.87 (2CH), 55.31 (CH3), 17.37 (CH3). 
LCMS(in MeOH): Rt = 1.79 min, m/z = 200.5[M+H]+; HR-MS: calculated for C13H14NO- 200.1075, 
found- 200.1078 (Δ= 1.5 ppm) 
 
IR (neat) ν = 2957.2 (w), 2836.8 (w), 1609.2 (m), 1515.1 (m), 1464.1 (m), 1286.2 (m), 1244.7 (s), 
1175.1 (m), 1041.8 (m), 1022.6 (m), 824.7 (s), 554.1 (m), 528.3 (m) 
 
4-(2,4-dimethoxyphenyl)-3-methylpyridine, 7j: 
 
Isolated yield: 84% 
1H NMR (400 MHz, Chloroform-d) δ 8.44 (s, 1H), 8.40 (d, J = 5.0 Hz, 1H), 7.07 (d, J = 4.9 Hz, 1H), 
7.03 – 6.98 (m, 1H), 6.58 – 6.51 (m, 2H), 3.84 (s, 3H), 3.73 (s, 3H), 2.11 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 161.05 (C), 157.24 (C), 150.50 (CH), 146.91 (CH), 146.48 (C), 
132.61 (C), 130.78 (CH), 124.98 (CH), 120.78 (C), 104.48 (CH), 98.64 (CH), 55.44 (CH3), 55.38 (CH3), 
16.86 (CH3). 
 
LCMS(in MeOH): Rt = 1.86 min, m/z = 230.5[M+H]+; HR-MS: calculated for C14H16NO2- 230.1181, 
found- 230.1185 (Δ= 1.7 ppm) 
 
IR (neat) ν = 2936.4 (w), 1610.3 (m), 1577.6 (m), 1464.6 (m), 1207.3 (s), 1154.5 (m), 1050.5 (s), 1033.2 
(m), 833.9 (s), 798.0 (m), 550.4 (m) 
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4-(2-trifluoromethylphenyl)-3-methylpyridine, 7k: 
 
Isolated yield: 49% 
1H NMR (400 MHz, Chloroform-d) δ 8.51 (s, 1H), 8.45 (d, J = 5.0 Hz, 1H), 7.80 (d, J = 8 Hz, 1H), 
7.60 (t, J = 7.7 Hz, 1H), 7.52 (t, J = 8 Hz, 1H), 7.18 (d, J = 8 Hz, 1H), 7.07 (d, J = 4.9 Hz, 1H), 2.03 (s, 
3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 150.66 (CH), 146.96 (C), 146.52 (CH), 137.56 (q, J = 2.1 Hz, 
C), 131.68 (CH), 131.43 (C), 130.45 (CH), 128.23 (q, J = 30.3 Hz, C) , 128.19 (CH), 126.27 (q, J = 5.1 
Hz, CH), 123.92 (app. d, J = 1.7 Hz, CH), 123.72 (q, J = 274.7 Hz, CF3) , 16.78 (CH3). 
 
19F NMR (376 MHz, Chloroform-d) δ -59.05 (3F). 
 
LCMS(in MeOH): Rt = 2.00 min, m/z = 238.1[M+H]+; HR-MS: calculated for C13H11 F3N- 238.0844, 
found- 238.0847 (Δ= 1.3 ppm) 
 
IR (neat) ν = 3034.5 (w), 1593.1 (w), 1479.6 (w), 1448.8 (w), 1405.1 (w), 1314.0 (s), 1169.8 
(m), 1108.6 (s), 1071.4 (m), 1034.3 (m), 835.6 (m), 769.3 (m), 654.2 (m), 601.7 (m) 
 
4-(3-trifluoromethylphenyl)-3-methylpyridine, 7l: 
 
Isolated yield: 55% 
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1H NMR (400 MHz, Chloroform-d) δ 8.55 (s, 1H), 8.52 (d, J = 5.0 Hz, 1H), 7.69 (d, J = 7.9 Hz, 1H), 
7.63 – 7.57 (m, 2H), 7.53 (d, J = 7.6 Hz, 1H), 7.16 (d, J = 5.0 Hz, 1H), 2.28 (s, 3H). 
13C NMR (101 MHz, Chloroform-d) δ 151.53 (CH), 147.60 (CH), 139.81 (C), 131.89 (CH), 131.01 (q, 
J = 32.6 Hz, C), 130.50 (C), 129.03 (CH), 125.34 (q, J = 3.8 Hz, CH), 124.81 (q, J = 3.8 Hz, CH), 
124.08 (q, J = 272.8 Hz, CF3), 123.78 (CH), 17.08 (CH3). 
19F NMR (376 MHz, Chloroform-d) δ -62.67 (s, 3F). 
LCMS(in MeOH): Rt = 2.30 min, m/z = 238.1[M+H]+; HR-MS: calculated for C13H11 F3N- 238.0844, 
found- 238.0835 (Δ= -3.8 ppm) 
 
IR (neat) ν = 3035.5 (w), 1591.3 (w), 1480.3 (w), 1403.9 (w), 1384.8 (w), 1333.6 (s), 1262.9 (m), 1163.7 
(m), 1120.4 (s), 1094.6 (m), 1073.8 (m), 1043.0 (m), 833.2 (m), 804.3 (m), 704.3 (m), 658.7 (m), 623.8 
(m) 
 
4-(4-trifluoromethylphenyl)-3-methylpyridine, 7m: 
 
Isolated yield: 64% 
1H NMR (400 MHz, Chloroform-d) δ 8.53 (s, 1H), 8.49 (d, J = 5.0 Hz, 1H), 7.71 (d, J = 8.0 Hz, 2H), 
7.43 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 5.0 Hz, 1H), 2.25 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 151.48 (CH), 147.75 (C), 147.53 (CH), 142.69 (app. d, J = 1.5 
Hz, C), 130.43 (C), 130.22 (q, J = 32.3 Hz, C), 128.95 (2CH), 125.47 (q, J = 3.7 Hz, 2CH), 124.03 (q, 
J = 272.7 Hz, CF3), 123.67 (CH), 17.07 (CH3). 
 
19F NMR (376 MHz, Chloroform-d) δ -62.63 (s, 3F). 
 
LCMS(in MeOH): Rt = 2.61 min, m/z = 238.1[M+H]+; HR-MS: calculated for C13H11 F3N- 238.0844, 
found- 238.0843 (Δ= -0.4 ppm) 
 
IR (neat) ν = 3033.9 (w), 1620.0 (w), 1591.4 (w), 1451.9 (w), 1321.9 (s), 1163.6 (m), 1121.5 
(s), 1107.5 (s), 1069.3 (s), 1031.1 (m), 828.4 (m), 723.0 (m), 612.4 (m) 
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4-(2-nitrophenyl)-3-methylpyridine, 7n: 
 
Isolated yield: 39% 
1H NMR (400 MHz, Chloroform-d) δ 8.58 – 8.40 (m, 2H), 8.10 (dd, J = 8.2, 1.3 Hz, 1H), 7.69 (td, J = 
7.6, 1.3 Hz, 1H), 7.59 (td, J = 8.2, 1.5 Hz, 1H), 7.27 (dd, J = 7.5, 1.5 Hz 1H), 7.03 (d, J = 4.9 Hz, 1H), 
2.07 (s, 3H). 
13C NMR (101 MHz, Chloroform-d) δ 150.78(CH), 148.00(C), 147.29(CH), 146.02(C), 138.96(C), 
133.96(CH), 133.32(CH), 131.28(CH), 130.86(C), 124.63(CH), 122.62(CH), 16.67(CH3). 
LCMS(in MeOH): Rt = 1.52 min, m/z = 215.0[M+H]+; HR-MS: calculated for C12H11 N2O2- 215.0821, 
found- 215.0827 (Δ= 2.8 ppm) 
 
IR (neat) ν = 2981.2 (m), 1737.2 (w), 1591.6 (m), 1521.4 (s), 1346.3 (s), 855.3 (m), 787.4 (m), 
746.6 (m), 668.6 (m), 526.6 (m) 
 
4-(3-nitrophenyl)-3-methylpyridine, 7o: 
 
Isolated yield: 70% 
1H NMR (400 MHz, Chloroform-d) δ 8.55 (s, 1H), 8.51 (d, J = 5.0 Hz, 1H), 8.29 – 8.24 (m, 1H), 8.20 
(dt, J = 2.2, 0.9 Hz, 1H), 7.68 – 7.64 (m, 2H), 7.16 (d, J = 4.9 Hz, 1H), 2.28 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 151.67 (CH), 148.30 (C), 147.75 (CH), 146.61 (C), 140.61 (C), 
134.61 (CH), 130.40 (C), 129.65 (CH), 123.67 (CH), 123.54 (CH), 122.98 (CH), 17.10 (CH3). 
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LCMS(in MeCN): Rt=1.66 min, m/z = 215.0 [M+H]+; HR-MS: calculated for C12H11N2O2 -  215.0821, 
found-  215.0830  (Δ= 4.2 ppm) 
 
IR (neat) ν = 2981.1 (m), 1736.5 (w), 1595.8 (w), 1524.8 (s), 1346.3 (s), 855.3 (m), 787.4 (m), 
746.6 (m), 668.6 (m), 526.6 (m) 
 
4-(4-nitrophenyl)-3-methylpyridine, 7p: 
 
Isolated yield: 79% 
1H NMR (400 MHz, Chloroform-d) δ 8.54 (s, 1H), 8.50 (d, J = 5.0 Hz, 1H), 8.32 – 8.27 (m, 2H), 7.52 
– 7.46 (m, 2H), 7.13 (d, J = 5.0 Hz, 1H), 2.25 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 151.63 (CH), 147.65 (CH), 147.56 (C), 146.85 (C), 145.59 (C), 
130.23 (C), 129.61 (2CH), 123.76 (2CH), 123.41 (CH), 17.10 (CH3). 
 
LCMS(in MeCN): Rt=1.69 min, m/z = 215.0 [M+H]+; HR-MS: calculated for C12H11N2O2 -  215.0821, 
found-  215.0830  (Δ= 4.2 ppm) 
 
IR (neat) ν = 2981.2 (m), 1738.1 (w), 1514.7 (s), 1347.9 (s), 855.7 (m), 836.9 (m), 814.8 (m), 738.5 
(m), 697.4 (m), 577.5 (m) 
4-(2-cyanophenyl)-3-methylpyridine, 7q: 
 
Isolated yield: 42% 
1H NMR (400 MHz, Chloroform-d) δ 8.59 (s, 1H), 8.54 (d, J = 5.0 Hz, 1H), 7.80 (ddd, J = 7.7, 1.4, 0.6 
Hz, 1H), 7.69 (app. td, J = 7.7, 1.4 Hz, 1H), 7.53 (app. td, J = 7.7, 1.2 Hz, 1H), 7.36 (ddd, J = 7.8, 1.3, 
0.6 Hz, 1H), 7.15 (d, J = 4.9 Hz, 1H), 2.20 (s, 3H). 
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13C NMR (101 MHz, Chloroform-d) δ 151.51(CH), 147.46(CH), 145.53(C), 142.74(C), 133.19(CH), 
132.81(CH), 130.98(C), 129.72(CH), 128.58(CH), 123.69(CH), 117.43(C), 112.18(C), 16.71(CH3). 
 
LCMS(in MeCN): Rt=1.42 min, m/z = 195.4 [M+H]+; HR-MS: calculated for C13H11N2 - 195.0922, 
found - 195.0932   (Δ= 5.1 ppm) 
 
IR (neat) ν = 2227.5 (m, CN), 1590.2 (m), 1443.4 (m), 1404.6 (m), 1192.6 (w), 836.8 (m), 768.5 (s), 
630.2 (m), 602.2 (m) 
 
4-(3-cyanophenyl)-3-methylpyridine, 7r: 
 
Isolated yield: 87% 
1H NMR (400 MHz, Chloroform-d) δ 8.53 (s, 1H), 8.49 (d, J = 5 Hz, 1H), 7.70 (dt, J = 6.9, 2.0 Hz, 
1H), 7.62 – 7.60 (m, 1H), 7.59 – 7.55 (m, 2H), 7.10 (d, J = 4.9 Hz, 1H), 2.25 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 151.61 (CH), 147.69 (CH), 146.74 (C), 140.30 (C), 132.96 (CH), 
132.01 (CH), 131.64 (CH), 130.36 (C), 129.48 (CH), 123.64 (CH), 118.36 (C), 112.90 (C), 17.08 (CH3). 
 
LCMS(in MeCN): Rt=1.48 min, m/z = 195.0 [M+H]+; HR-MS: calculated for C13H11N2 - 195.0922, 
found - 195.0915   (Δ= -3.6 ppm) 
 
IR (neat) ν = 2981.2 (s), 2230.9 (m, CN), 1738.3 (s), 1591.6 (m), 1380.5 (s), 838.1 (m), 805.0 (s), 700.7 
(s), 587.4 (m), 488.8 (m) 
4-(4-cyanophenyl)-3-methylpyridine, 7s: 
 
Isolated yield: 68% 
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1H NMR (400 MHz, Chloroform-d) δ 8.54 (s, 1H), 8.51 (d, J = 5.0 Hz, 1H), 7.78 – 7.72 (m, 2H), 7.48 
– 7.40 (m, 2H), 7.11 (d, J = 5.0 Hz, 1H), 2.25 (s, 3H). 
 
13C NMR (101 MHz, Chloroform-d) δ 151.66 (CH), 147.69 (CH), 147.18 (C), 143.72 (C), 132.33 
(2CH), 130.19 (C), 129.39 (2CH), 123.42 (CH), 118.46 (C), 112.08 (C), 17.08 (CH3). 
 
LCMS(in MeOH): Rt=1.48 min, m/z = 195.0 [M+H]+; HR-MS: calculated for C13H11N2 - 195.0922, 
found - 195.0924   (Δ= 1.0 ppm) 
 
IR (neat) ν = 2981.2 (m), 2228.3 (m, CN), 1738.8 (m), 1592.1 (m), 1404.49 (m), 1376.9 (m), 1230.6 
(m), 826.4 (m), 559.4 (s), 516.4 (m) 
 
3,5-dimethylpyridine-N-oxide (3,5-lutidine-N-oxide), 8: 
 
Isolated yield: 56% 
1H NMR (400 MHz, Chloroform-d) δ 7.90 (s, 2H), 6.90 (s, 1H), 2.25 (s, 6H). 
 
4-nitro-3,5-dimethylpyridine-N-oxide (4-nitro-3,5-lutidine-N-oxide), 9: 
 
Isolated yield: 63% 
1H NMR (400 MHz, Chloroform-d) δ 7.98 (s, 2H), 2.30 (s, 6H). 
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4-bromo-3,5-dimethylpyridine-N-oxide (4-bromo-3,5-lutidine-N-oxide), 10: 
 
Isolated yield: 58% 
1H NMR (400 MHz, Chloroform-d) δ 7.95 (s, 2H), 2.33 (d, 6H). 
 
 
4-bromo-3,5-dimethylpyridine hydrochloride (4-bromo-3,5-lutidine hydrochloride), 11b: 
 
Isolated yield: 60% 
1H NMR (400 MHz, Methanol-d4) δ 8.66 (s, 2H), 2.64 (s, 6H). 
 
 
4-phenyl-3,5-dimethylpyridine, 12a: 
 
Isolated yield: 65% 
1H NMR (400 MHz, Chloroform-d) δ 8.34 (s, 2H), 7.48 – 7.41 (m, 2H), 7.41 – 7.34 (m, 1H), 7.14 – 
7.07 (m, 2H), 2.01 (s, 6H). 
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13C NMR (101 MHz, Chloroform-d) δ 149.33 (C), 148.37 (2CH), 138.10 (C), 130.81 (2C), 
128.71(2CH), 128.00 (2CH), 127.51 (CH), 17.29 (2CH3). 
LCMS(in MeOH): Rt = 1.89 min, m/z = 184.1[M+H]+; HR-MS: calculated for C13H13N- 184.1126, 
found- 184.1126 (Δ= 0.0 ppm) 
 
IR (neat) ν = 2970.3 (w), 1584.3 (m), 1472.6 (m), 1441.1 (m), 1410.2 (m), 1159.4 (m), 877.8 (m), 774.7 
(m), 711.3 (s), 755.4 (s), 667.0 (m), 588.8 (m), 523.9 (m) 
 
Melting point: 85.7 – 88.0 oC (1:9::AcOEt:Hexanes) 
 
4-(2-methylphenyl)-3,5-dimethylpyridine, 12b: 
 
Isolated yield: 69% 
Melting point: 70.9 – 72.1oC, dried from 10% AcOEt solution in Hexanes. 
1H NMR (400 MHz, Chloroform-d) δ 8.34 (s, 2H), 7.32 – 7.21 (m, 3H), 6.97 – 6.90 (m, 1H), 1.95 (s, 
3H), 1.93 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.94(C), 148.37(2CH), 137.57(C), 134.63(C), 130.88(2C), 
130.28(CH), 127.80(CH), 127.69(CH), 126.30(CH), 19.22(CH3), 16.87(2CH3). 
LCMS(in MeOH): Rt=1.89 min, m/z = 198.1 [M+H]+; HR-MS: calculated for C14H16N - 198.1283, 
found - 198.1281   (Δ= -1.0 ppm) 
 
IR (neat) ν = 2919.5 (w), 1584.3 (m), 1450.0 (m), 1410.1 (m), 1378.0 (m), 1156.2 (m), 881.4 (m), 764.9 
(s), 752.8 (m), 600.1 (m), 462.7 (m) 
Melting point: 70.9 – 72.1 oC (1:9::AcOEt:Hexanes) 
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4-(3-methylphenyl)-3,5-dimethylpyridine, 12c: 
 
Isolated yield: 45% 
1H NMR (400 MHz, Chloroform-d) δ 8.32 (s, 2H), 7.32 (t, J = 7.5 Hz, 1H), 7.18 (d, J = 7.7 Hz, 1H), 
6.93 – 6.86 (m, 2H), 2.38 (s, 3H), 2.01 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 149.45(C), 148.34(2CH), 138.31(C), 138.06(C), 130.78(2C), 
128.57(CH), 128.54(CH), 128.19(CH), 125.00(CH), 21.48(CH3), 17.29(2CH3). 
LCMS(in MeOH): Rt = 2.27 min, m/z = 198.1 [M+H]+; HR-MS: calculated for C14H16N - 198.1283, 
found - 198.1286   (Δ= 1.5 ppm) 
 
IR (neat) ν = 2920.2 (w), 1583.4 (m), 1472.1 (m), 1446.9 (m), 1382.0 (m), 1156.9 (m), 885.8 (m), 796.8 
(m), 763.9 (m), 746.5 (m), 711.9 (s), 591.0 (m), 455.7 (m) 
Melting point: 65.2 – 66.3 oC (1:9::AcOEt:Hexanes) 
 
4-(4-methylphenyl)-3,5-dimethylpyridine, 12d: 
 
 
Isolated yield: 36% 
 
1H NMR (400 MHz, Chloroform-d) δ 8.34 (s, 2H), 7.30 – 7.24 (m, 2H), 7.04 – 6.98 (m, 2H), 2.42 (s, 
3H), 2.09 – 1.97 (m, 6H). 
 
13C NMR (101 MHz, Chloroform-d) δ 149.39 (C), 148.34 (2CH), 137.14 (C), 135.06 (C), 130.97 (2C), 
129.37 (2CH), 127.89 (2CH), 21.26 (CH3), 17.33 (2CH3). 
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LCMS(in MeOH): Rt= 2.27 min, m/z = 198.1 [M+H]+; HR-MS: calculated for C14H16N - 198.1283, 
found - 198.1280   (Δ= -1.5 ppm) 
 
IR (neat) ν = 2920.1 (w), 1584.5 (m), 1514.2 (m), 1447.8 (m), 1407.8 (m), 1157.7 (m), 884.0 
(m), 815.4 (s), 752.0 (m), 585.0 (m), 523.3 (s) 
 
 
4-(2-methoxyphenyl)-3,5-dimethylpyridine, 12f: 
 
Isolated yield: 47% 
1H NMR (400 MHz, Chloroform-d) δ 8.31 (s, 2H), 7.36 (ddd, J = 8.3, 7.3, 1.9 Hz, 1H), 7.04 – 6.94 (m, 
3H), 3.71 (s, 3H), 1.98 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 155.91 (C), 148.04 (2CH), 146.36 (C), 131.58 (2C), 129.56 
(CH), 129.28 (CH), 126.60 (C), 120.85 (CH), 111.03 (CH), 55.39 (CH3), 16.99 (2CH3). 
LCMS(in MeOH): Rt= 1.69 min, m/z = 214.1 [M+H]+; HR-MS: calculated for C14H16NO - 214.1232, 
found – 214.1232   (Δ= 0.0 ppm) 
 
IR (neat) ν = 2957.2 (w), 1601.6 (m), 1581.8 (m), 1435.0 (m), 1251.4 (s), 1230.1 (m), 1161.7 
(m), 1120.2 (m), 1052.6 (m), 1026.4 (m), 804.7 (m), 753.8 (s), 662.6 (m), 539.4 (m) 
 
 
4-(3-methoxyphenyl)-3,5-dimethylpyridine, 12g: 
 
Isolated yield: 49% 
1H NMR (400 MHz, Chloroform-d) δ 8.33 (s, 2H), 7.36 (dd, J = 8.4, 7.5 Hz, 1H), 6.91 (ddd, J = 8.3, 
2.6, 1.0 Hz, 1H), 6.68 (app. dt, J = 7.5, 1.2 Hz, 1H), 6.64 (dd, J = 2.6, 1.5 Hz, 1H), 3.81 (s, 3H), 2.03 
(s, 6H). 
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13C NMR (101 MHz, Chloroform-d) δ 159.84(C), 149.14(C), 148.38(2CH), 139.49(C), 130.72(2C), 
129.86(CH), 120.32(CH), 113.73(CH), 112.77(CH), 55.25(CH3), 17.20(2CH3). 
 
LCMS(in MeOH): Rt= 2.03 min, m/z = 214.1 [M+H]+; HR-MS: calculated for C14H16NO - 214.1232, 
found – 214.1234   (Δ= 0.9 ppm) 
 
IR (neat) ν = 3002.8 (w), 2968.7 (w), 1574.9 (m), 1466.8 (m), 1291.5 (m), 1208.1 (s), 1173.0 (m), 
1054.6 (m), 1030.8 (m), 874.3 (m), 790.8 (s), 746.7 (s), 712.8 (s), 563.4 (m) 
Melting point: 93.2 – 95.6 oC (1:9::AcOEt:Hexanes) 
 
4-(4-methoxyphenyl)-3,5-dimethylpyridine, 12h: 
 
Isolated yield: 56% 
1H NMR (400 MHz, Chloroform-d) δ 8.30 (s, 2H), 7.05 – 6.92 (m, 4H), 3.83 (s, 3H), 2.01 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 158.89 (C), 149.08 (C), 148.36 (2CH), 131.23 (C), 130.25 (C), 
129.23 (2CH), 114.10 (2CH), 55.24 (CH3), 17.35 (CH3). 
LCMS(in MeOH): Rt= 2.00 min, m/z = 214.1 [M+H]+; HR-MS: calculated for C14H16NO - 214.1232, 
found – 214.1227   (Δ= -2.3 ppm) 
 
IR (neat) ν = 2958.5 (w), 1610.1 (m), 1516.0 (m), 1465.2 (m), 1292.5 (m), 1241.1 (s), 1173.7 
(m), 1043.3 (m), 831.6 (m), 807.3 (m), 767.7 (m), 534.8 (m) 
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4-(2,4-dimethoxyphenyl)-3,5-dimethylpyridine, 12i: 
 
Isolated yield: 71% 
1H NMR (400 MHz, Chloroform-d) δ 8.28 (s, 2H), 6.89 – 6.80 (m, 1H), 6.60 – 6.49 (m, 2H), 3.82 (s, 
3H), 3.67 (s, 3H), 1.97 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 160.71 (C), 157.01 (C), 148.03 (2CH), 146.19 (C), 132.10 (2C), 
130.01 (CH), 119.21 (C), 104.63 (CH), 98.81 (CH), 55.42 (CH3), 55.38 (CH3), 17.05 (2CH3). 
LCMS(in MeOH): Rt= 2.07 min, m/z = 244.2 [M+H]+; HR-MS: calculated for C15H18NO2 - 244.1338, 
found – 244.1337   (Δ= -0.4 ppm) 
 
IR (neat) ν = 2958.9 (w), 1610.7 (m), 1579.6 (m), 1510.8 (m), 1304.1 (m), 1206.1 (s), 1157.0 (s), 1029.5 
(m), 833.4 (m), 531.6 (m) 
 
4-(3-trifluoromethylphenyl)-3,5-dimethylpyridine, 12k: 
 
Isolated yield: 45% 
1H NMR (400 MHz, Chloroform-d) δ 8.37 (s, 2H), 7.66 (d, J = 7.9 Hz, 1H), 7.60 (t, J = 7.8 Hz, 1H), 
7.40 (s, 1H), 7.33 (d, J = 7.9 Hz, 1H), 2.01 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.64(2CH), 147.63(C), 138.87(C), 131.57 (app. d, J = 1.4 Hz, 
CH), 131.29 (q, J = 32.6 Hz, C), 130.54(2C), 129.36(CH), 124.93 (q, J = 3.7 Hz, CH), 124.51 (q, J = 
3.8 Hz, CH), 123.96 (q, J = 275.3 Hz, CF3), 17.24(2CH3). 
19F NMR (376 MHz, Chloroform-d) δ -62.65(3F). 
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LCMS(in MeOH): Rt= 0.87 min, m/z = 252.1 [M+H]+; HR-MS: calculated for C14H12F3N - 252.1000, 
found – 252.1001   (Δ= 0.4 ppm) 
IR (neat) ν = 2972.6 (w), 1742.6 (w), 1584.0 (w), 1478.4 (w), 1382.7 (w), 1328.6 (s), 1242.9 (m), 1120.3 
(m), 1092.1 (s), 1074.6 (s), 1041.7 (m), 905.4 (m), 876.2 (m), 816.7 (m), 711.8 (m), 685.8 (m) 
Melting point: 79.6 – 80.7 oC (1:9::AcOEt:Hexanes) 
 
4-(4-trifluoromethylphenyl)-3,5-dimethylpyridine, 12l: 
 
Isolated yield: 58% 
1H NMR (400 MHz, Chloroform-d) δ 8.36 (s, 2H), 7.72 (d, J = 7.8 Hz, 2H), 7.26 (d, J = 7.8 Hz, 2H), 
2.00 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.60(2CH), 147.80(C), 141.89 (app. d, J = 1.6 Hz, C), 
130.38(2C), 129.94 (q, J = 32.7 Hz, C), 128.58(2CH), 125.80 (q, J = 3.8 Hz, 2CH), 124.06 (q, J = 273.0 
Hz, CF3), 17.20(2CH3). 
19F NMR (376 MHz, Chloroform-d) δ -62.61(3F). 
LCMS(in MeOH): Rt= 2.58 min, m/z = 252.1 [M+H]+; HR-MS: calculated for C14H12F3N - 252.1000,  
found – 252.1005   (Δ= 2.0 ppm) 
 
IR (neat) ν = 2970.4 (w), 1737.2 (w), 1616.0 (w), 1584.5 (w), 1379.1 (w), 1320.6 (m), 1159.2 (m), 
1105.4 (s), 1031.5 (m), 1019.2 (m), 889.8 (m), 753.8 (m), 613.5 (m)  
Melting point: 89.2 – 90.4 oC (1:9::AcOEt:Hexanes) 
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4-(3-nitrophenyl)-3,5-dimethylpyridine, 12n: 
 
Isolated yield: 53% 
1H NMR (400 MHz, Chloroform-d) δ 8.39 (s, 2H), 8.27 (ddd, J = 8.3, 2.3, 1.1 Hz, 1H), 8.04 (app. s, 
1H), 7.69 (t, J = 7.9 Hz, 1H), 7.50 (dt, J = 7.6, 1.3 Hz, 1H), 2.03 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.77 (2CH), 148.57 (C), 146.59 (C), 139.70 (C), 134.45 (CH), 
130.38 (2C), 129.99 (CH), 123.24 (CH), 122.74 (CH), 17.26 (2CH3). 
LCMS(in MeOH): Rt= 1.83 min, m/z = 229.1 [M+H]+; HR-MS: calculated for C13H13N2O2 – 229.0977, 
found – 229.0979 (Δ= 0.9 ppm) 
 
IR (neat) ν = 2921.2 (w), 1741.4 (w), 1587.7 (w), 1525.9 (m), 1348.4 (s), 1162.9 (m), 1091.9 (m), 880.9 
(m), 736.2 (m), 700.8 (s) 
Melting point: 112.4 – 113.4 oC (1:4::AcOEt:Hexanes) 
 
4-(4-nitrophenyl)-3,5-dimethylpyridine, 12o: 
 
Isolated yield: 42% 
1H NMR (400 MHz, Chloroform-d) δ 8.42 (s, 2H), 8.37 (d, J = 8.6 Hz, 2H), 7.36 (d, J = 8.6 Hz, 2H), 
2.04 (s, 6H). 
 
13C NMR (101 MHz, Chloroform-d) δ 148.72 (2CH), 147.50 (C), 147.01 (C), 145.01 (C), 130.05 (2C), 
129.31 (2CH), 124.17 (2CH), 17.23 (2CH3). 
 
LCMS(in MeOH): Rt= 1.89 min, m/z = 229.1 [M+H]+; HR-MS: calculated for C13H13N2O2 – 229.0977, 
found – 229.0967 (Δ= -4.4 ppm) 
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IR (neat) ν = 1600.7 (w), 1582.9 (w), 1515.2 (s, NO2), 1345.6 (s, NO2), 1163.2 (w), 1102.9 (w), 856.0 
(s), 776.4 (m), 748.2 (m), 702.6 (m), 588.3 (m), 459.4 (m) 
 
4-(2-cyanophenyl)-3,5-dimethylpyridine, 12q: 
 
Isolated yield: 12% 
1H NMR (400 MHz, Chloroform-d) δ 8.45 (s, 2H), 7.84 (dd, J = 7.8, 1.4 Hz, 1H), 7.74 (td, J = 7.7, 1.4 
Hz, 1H), 7.56 (td, J = 7.7, 1.2 Hz, 1H), 7.31 – 7.25 (m, 1H), 2.05 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.71 (2CH), 145.39 (C), 142.08 (C), 133.30 (CH), 133.23 
(CH), 130.60 (2C), 129.25 (CH), 128.45 (CH), 117.07 (C), 112.17 (C), 16.94 (2CH3). 
LCMS(in MeOH): Rt= 1.31 min, m/z = 209.1 [M+H]+; HR-MS: calculated for C14H13N2 – 209.1079, 
found – 209.1085   (Δ= 2.9 ppm) 
 
IR (neat) ν = 2226.2 (m, CN), 1584.3 (m), 1470.3 (m), 1444.6 (m), 1163.6 (m), 879.0 (m), 761.3 (s), 
768.7 (s), 742.5 (m), 518.4 (m) 
 
4-(3-cyanophenyl)-3,5-dimethylpyridine, 12r: 
 
Isolated yield: 60% 
1H NMR (400 MHz, Chloroform-d) δ 8.37 (s, 2H), 7.70 (app. dt, J = 7.8, 1.4 Hz, 1H), 7.60 (td, J = 7.7, 
0.6 Hz, 1H), 7.44 (app. td, J = 1.7, 0.6 Hz, 1H), 7.38 (dt, J = 7.7, 1.5 Hz, 1H), 2.00 (s, 6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.74(2CH), 146.73(C), 139.42(C), 132.70(CH), 131.65(CH), 
131.41(CH), 130.38(2C), 129.80(CH), 118.38(C), 113.20(C), 17.25(2CH3). 
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LCMS(in MeOH): Rt= 1.52 min, m/z = 209.1 [M+H]+; HR-MS: calculated for C14H12N2 - 209.1079, 
found – 252.1079   (Δ= 0.0 ppm) 
 
IR (neat) ν = 2919.2 (w), 2228.3 (m, CN), 1585.9 (m), 1471.5 (m), 1411.1 (m), 1381.1 (m), 1159.4 (m), 
877.1 (m), 805.9 (s), 701.3 (s), 598.7 (m), 496.8 (s) 
 
4-(4-cyanophenyl)-3,5-dimethylpyridine, 12s: 
 
Isolated yield: 60% 
1H NMR (400 MHz, Chloroform-d) δ 8.36 (s, 2H), 7.82 – 7.71 (m, 2H), 7.31 – 7.23 (m, 2H), 2.00 (s, 
6H). 
13C NMR (101 MHz, Chloroform-d) δ 148.66(2CH), 147.26(C), 143.01(C), 132.66(2CH), 130.06(2C), 
129.09(2CH), 118.49(C), 111.80(C), 17.18(2CH3). 
LCMS(in MeOH): Rt= 1.54 min, m/z = 209.1 [M+H]+; HR-MS: calculated for C14H12N2 - 209.1079, 
found – 252.1075   (Δ= -1.9 ppm) 
IR (neat) ν = 2919.0 (w), 2227.2 (m, CN), 1570.0 (m), 1477.3 (m), 1412.7 (m), 1349.6 (m), 848.1 (s), 
585.6 (s), 548.9 (s), 499.7 (m) 
Melting point: 166.3 – 169.0 oC (3:7::AcOEt:Hexanes) 
 
 
 
 
 
 
 
 
 
105 
 
References: 
 
1: Bissantz C, Kuhn B, Stahl M, J. Med. Chem., 2010, 53, p5061-5084. 
2: McGaughey G.B, Gagne M, Rappe A.K, J. Biol. Chem., 1998, 273, p15458-15463. 
3: van der Spoel, van Buuren A.R, Tieleman D.P, Berendsen H.J.C, J. Biomol. NMR, 1996, 8, p229-238. 
4: Zacharias N, Dougherty D.A, Trends Pharmacol. Sci., 2002, 23, p281-287. 
5: Hadjuk P.J, Bures M, Praestgaard J, Fesik S.W, J. Med. Chem., 2000, 43, p3443-3447. 
6: Schnur D.M, Beno B.R, Good A, Tebben A.J, J. Med. Chem., 2006, 49, p2000. 
7: Martin R, Buchwald S.L, Acc. Chem. Res., 2008, 41, p1461-1473. 
8: Wu S, He M, Zhang X, Tetrahedron: Asymmetry, 2004, 41, p2177-2180. 
9: Kanthasamy K, Pfnur H, Beilstein J. Nanotechnol., 2015, 6, 1690-1697. 
10: de Gennes D.G, Prost J, In: “The Physics of Liquid Crystals”, Oxford: Clarendon Press, 1995, 2, 4. 
11: Lim E.C, Li Y.H,  J. Chem. Phys., 1970, 52, p6416-6422. 
12: Loyd-Williams P, Giralt E, Chem. Soc. Rev., 2001, 30, p146. 
13:  Trotter J, Acta. Cryst., 1961, 14, p1135-1140. 
14: Bastiensen O, Acta. Chem. Scand., 1949, 3, p408. 
15: Eaton V.J, Steele V.D, J. Chem. Soc. Faraday Trans. 2, 1973, 69, 1601-1608. 
16: Imamura A, Hoffmann R, J. Am. Chem. Soc., 1968, 90, p5379. 
17: Kato M, Higashi M, Taniguchi Y, J. Chem. Phys., 1988, 89, p5417-5421. 
18: Oki K, “Recent Advances in atropisomerism”, In: Allinger N.L, Eliel E.E, Wilen S.H (editors), “Topics 
in Stereochemistry”, New York: Wiley Interscience, 1983, 14, p9. 
19: LaPlante S.R, Fader L.D, Fandrick K.R, Fandrick D.R, Hucke O, Kemper R, Miller S.P.F, Edwards P.J, 
J. Med. Chem., 2011, 54, p7005-7022.  
20: Mikami K, Aikawa K, Yusa Y, Jodry J.J, Yamanaka M, Synlett., 2002, 10, p1561-1578. 
21: Christie G.H, Kenner J, J. Chem. Soc. Trans., 1922, 121, p614-620. 
22: Cahn R.S, J. Chem. Educ., 1964, 41, 116. 
23: Bringmann G, Mortimer A.P.J, Keller, P.A, Gresser M.J, Garner J, Breuning M, Angew. Chem. Int. 
Ed., 2005, 44, p5384-5427. 
24: Bringmann G, Menche D, Bezabih M, Abegaz B.M, Kaminsky R, Planta. Med., 1999, 65, p757-758. 
25: Sprogoe K, Stark D, Ziegler H.L, Jensen T.H, Holm-Moller S.B, Jaroszewski J.W, J. Nat. Prod., 2008, 
71, p516-519. 
26: Casy A.F, Magn. Reson. Chem., 1993, 31, p416-417. 
106 
 
27: Smyth J.E, Butler N.M, Keller P.A, Nat. Prod. Rep., 2015, 32, p1562-1583. 
28: Eliel,E.L., “Stereochemistry of Carbon Compounds”, McGraw-Hill Book Company  
Inc., 1962, p22. 
29: Chhabra N, Aseri M.L, Padmanabhan D, Int. J. App. Basic. Med. Res., 2013, 3, p16-18. 
30: Knoche B, Blaschke G, Chirality, 1994, 6, p221-224. 
31: Zask A, Murphy J, Ellestad G.A, Chirality, 2013, 25, p265-274. 
32: Boger D.L, Beresis R.T, Loiseleur O, Wu J.H, Castle S.L, Bioorg. Med. Chem. Lett., 1998, 8, p721-
724. 
33: Boger D.L, Miyazaki S, Kim S.H, Wu J.H, Loiseleur O, Castle S.L, Jin Q, J. Am. Chem. Soc., 1999, 
121, p10004-10011. 
34: Clayden J, Chem. Commun., 2004, 2, p127-135. 
35: Bringmann G, Menche D, Kraus J, Muhlbache J, Peters K, Peters E, Brun R, Bezabih M, Abegaz 
B.M, J. Org. Chem., 2002, 67, p5595-5610. 
36: Gustafson J.L, Lim D, Miller S.J, Science, 2010, 328, p1251-1255. 
37: Yoon T.P, Jacobsen E.N, Science, 2003, 299, p1691-1693. 
38: Meca L, Reha D, Hawlas Z, J. Org. Chem., 2003, 68, p5677-5680. 
39: Garcia J.S, Lepetit C, Canac Y, Chauvin R, Boggio-Pasqua M, Chem. Asian J., 2014, 9, p462-465. 
41: Mikami K, Aikawa K, Yusa Y, Jodry J.J, Yamanaka M, SynLett., 2002, 10, p1561-1578. 
42: Aikawa M, Mikami K, Chem. Commun., 2012, 48, p11050-11069. 
43: Oczipka P, Muller D, Leitner W, Francio G, Chem. Sci., 2016, 7, p678-683. 
44: Nagrady T, Weaver D.F, In: “Medicinal Chemistry: A Molecular and Biochemical Approach”, New 
York: Oxford University Press, Inc., 2005, 3, p36. 
44: Lai Y, Xing L, Poda G.I, Hu Yiding, Drug Metab. Dispos., 2007, 35, p937-945. 
45: Forest J, Bazylewski P, Bauer R, Hong S, Kim C.Y, Giesy J.P, Seong Khim J, Soo Changg G, Front. 
Mar. Sci., 2014, 1, p1-7. 
46: Hinreiner M, Ryndyk D.A, Usyvat D, Merz T, Schutz M, Richter K, Phys. Status Solidi. B, 2013, 250, 
p2408-2416. 
47: Xia C.J, Fang C.F, Peng Z, Shi-Jie X, De-Sheng L, Phys. Lett. A, 2009, 373, p3787-3794. 
48: Buerkle M, Zotti L.A, Viljas J.K, Vonlanthen D, Mischenko A, Wandlowski T, Mayor M, Schoen G, 
Pauly F, Phys. Rev. B, 2012, 86, p115304-115308. 
49: Wang L.H, Guo Y, Tian C.F, Song X.P, Ding B.J, Phys. Lett. A, 2010, 374, p4876-4879. 
50: Page P.C.B, Bartlett C.J, Chan Y, Allin S.M, McKenzie M.J, Lacour J, Garth A.J, Org. Biomol. Chem., 
2016, 14, p4220-4232. 
107 
 
51: Cobley C.J, Froes R.D.J, Klosin J, Qin C, Whiteker G.T, Abboud K.A, Organometallics, 2007, 26, 
p2986-2999. 
52: Bott G, Field L.D, Sternhell S, J. Am. Chem. Soc., 1980, 102, p5618-5626. 
53: Meyer W.L, Meyer R.B, J. Am. Chem. Soc.¸ 1963, 85, p2170-2171. 
54: Michinori O, Iwamura H, Hayakawa N, Bull. Chem. Soc. Jap.¸ 1964, 37, p1865-1870. 
55: Colebrook L.D, Jahnke J.A, J. Am. Chem. Soc.¸ 1968, 90, p4687-4690. 
56: Klaus M, Willi H, Klaemer F.G, Roth W.R, Kindermann I, Adamczako O, Wette M, Johann L, Chem. 
Ber., 1990, 123, p2349-2371. 
57: Lunazzi L, Mancinelli M, Mazzanti A, Lepri S, Ruzziconi R, Schlosser M, Org. Biomol. Chem., 2012, 
10, p1847-1855. 
58: Wesseloh G, Wolf C, Koenig W.A, Chirality, 1996, 8, p441-445. 
59: Veciana J, Crespo M.J, Angew. Chem. Int. Ed. Engl., 1990, 30, p74-76. 
60: Trapp O, Chirality, 2006, 18, p489-497. 
61: Wolf C, Koenig W.A, Roussel C, Liebigs Ann., 1995, 5, p781-786. 
62: Wolf C, Hochmuth D.H, Koenig W.A, Roussel C, Liebigs Ann., 1996, 3, p357-363. 
63: Bihlmeier A, Rotzler J, Rickhaus M, Mayor M, Klopper W, Phys. Chem. Chem. Phys., 2015, 17, 
p11165-11173. 
64: Storch G, Maier F, Wessig P, Trapp O, Eur. J. Org. Chem., 2016, DOI:10.1002/ejoc.201600836. 
65: Sherer E.C, Lee C.H, Shpungin J, Cuff J.F, Da C, Ball R, Bach R, Crespo A, Gong X, Welch C.J, J. Med. 
Chem., 2014, 57, p477-494. 
66: Okuom M.O, Burks R, Naylor C, Homes A.E, J. Anal. Methods Chem., 2015, ArticleID: 865605.  
67: Pivonka D.E, Wesolowski S.S, Appl. Spectrosc., 2013, 67, p365-371. 
68: Grein F, J. Phys. Chem. A, 2002, 106, p3823-3827. 
69: Buevich A.V, J. Org. Chem., 2016, 81, p485-501. 
70: Masson E, Org. Biomol. Chem., 2013, 11, p2859-2871. 
71: Zhang L, Peslherbe G.H, Muchall H.M, Can. J. Chem., 2010, 88, p1175-1185. 
72: Gomez-Gallago M, Martin-Ortiz M, Sierra M.A, Eur. J. Org. Chem., 2011, 32, p6502-6506. 
73: Vonlanthen D, Rotzler J, Neuberger M, Mayor M, Eur. J. Org. Chem., 2010, 1, p120-133. 
74: Akiyama M, Watanabe T, Kakihana M, J. Phys. Chem., 1986, 90, p1752-1755. 
75: Dynes J.J, Baudais F.L, Boyd R.K, Can. J. Chem., 1985, 63, p1292-1299. 
76: Egolf D.S, Jurs P.C, Anal. Chem., 1990, 62, p1746-1754. 
77: Barich D.H, Pugmire R.J, Grant D.M, Iulliuci R.J, J. Phys. Chem. A, 2001, 105, p6780-6784. 
78: Leroux F, ChemBioChem, 2004, 5, p644-649. 
108 
 
79: Jia J, Wu H-S, Chen Z, Mo Y, Eur. J. Org. Chem., 2013, 3, 611-616. 
78: Sullivan J.J, Jones A.D, Tanji K.K, J. Chem. Inf. Comput. Sci., 2000, 40, 1113-1127. 
80: Peralta-Inga Z, Murray J.S, Politzer P, J. Org. Chem., 2001, 66, 6919-6925. 
81: Hansch C, Leo A, Taft R.W, Chem. Rev., 1991, 91, 165-195. 
82: Byron D.J, Gray G.W, Wilson R.C, J. Chem. Soc. C, 1966, 831-836. 
83: Byron D.J, Gray G.W, Wilson R.C, J. Chem. Soc. C, 1966, 837-840. 
84: Schneider H.J, Hoppen V.J, J. Org. Chem., 1978, 43, 3866. 
85: Busing W.R, Acta. Cryst. A, 1983, 39, 340-347. 
86: Wu X, Anbarasan P, Neumann H, Beller M, Angew. Chem. Int. Ed., 2010, 49, 9047-9050. 
87: Kang H, Facchetti A, Stern C.L, Rheingold A.L, Kassel W.S, Marks T.J, Org. Lett., 2005, 7, p3721-
3724. 
88: Conejo-Garcia A, Pisani L, Nunez M.C, Catto M, Nicolotti O, Leonetti F, Campos J.M, Gallo M.A, 
Espinosa A, Carotti A, J. Med. Chem., 2011, 54, 2627-2645. 
89: Diemer V, Helene C, Defoin A, Fort A, Boeglin A, Carre C, Eur. J. Org. Chem., 2008, 10, 1767-1776. 
90: Feast W.J, Tsibouklis J, Polym. Int., 1994, 35, 67-74. 
91: Bonin H, Fouquet E, Felpin F, Adv. Synth. Catal., 2011, 353, 3063-3084. 
92: Joule J.A, Mills K, In: “Heterocyclic Chemistry”, John Wiley&Sons, 2010, 146.  
93: Kassanova A.Z, Krasnokutskaya E.A, Beisembai P.S, Filimonov V.D, Synthesis, 2016, 48, 256-262. 
94: Espino G, Kurbangalieva A, Brown J.M, Chem. Commun., 2007, 1742-1744. 
95: Walker S.D, Barder T.E, Martinelli J.R, Buchwald S.L, Angew. Chem. Int. Ed., 2004, 43, 1871-1876. 
96: Andon R.J.L, Cox J.D, Herington E.F.G, Trans. Faraday. Soc., 1954, 50, 918-927. 
97: Espinosa S, Bosch E, Rosés M, Anal. Chem., 2000, 72, 5193-5200. 
98: Espinosa S, Bosch E, Rosés M, Analytica Chimica Acta, 2002, 454, 157-166. 
99: Dewar M.J.S, Grisdale P.J, J. Am. Chem. Soc., 1962, 84, 3539-3541. 
100: Campanelli A.R, Domenicano A, Ramondo F, J. Phys. Chem. A, 2012, 116, 8209-8217. 
101: Schulman E.M, Christensen K.A, Grant D.M, Walling C, J. Org. Chem., 1974, 39, 2686-2690. 
102: Greenwood N.N, In: “Spectroscopic Properties of Inorganic and Organometallic Compounds”, 
London: The Chemical Society, 1971, 4, 298-299. 
103: Cavallo G, Metrangolo P, Milani R, Pilati T, Priimagi A, Resnati G, Terraneo G, Chem. Rev., 2016, 
116, 2478-2601. 
104: Williams D.H, Fleming I, In: “Spectroscopic Methods in Organic Chemistry”, New York: The 
McGraw-Hill Companies Inc., 2008, 6, 38. 
105: Fuson N, Josien M-L, Shelton E.M, J. Am. Chem. Soc., 1954, 76, 2526-2533. 
109 
 
106: Hoffmann R.V, In: “Organic Chemistry: An Intermediate Text”, Hoboken, New Jersey: Wiley 
Interscience, 2004, 2, 167. 
107: Olah G.A, Surya Prakash G.K, Shih J.G, Krishnamurthy V.V, Mateescu G.D, Liang G, Sipos G, Buss 
V, Gund T.M, Schleyer PvR, J. Am. Chem. Soc., 1985, 107, 247-255. 
108: Reid K.S.C, Lindley P.F, Thornton J.M, FEBS Lett., 1985, 190, 209-213. 
 
 
 
 
 
 
 
 
 
 
